<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN"  "JATS-archivearticle1-3-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">86478</article-id><article-id pub-id-type="doi">10.7554/eLife.86478</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cell Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Neuroscience</subject></subj-group></article-categories><title-group><article-title>O-GlcNAc signaling increases neuron regeneration through one-carbon metabolism in <italic>Caenorhabditis elegans</italic></article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="author-307756"><name><surname>Yadav</surname><given-names>Dilip Kumar</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-0232-7387</contrib-id><email>dyadav1@bu.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-307757"><name><surname>Chang</surname><given-names>Andrew C</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-341712"><name><surname>Grooms</surname><given-names>Noa WF</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-268504"><name><surname>Chung</surname><given-names>Samuel H</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-247371"><name><surname>Gabel</surname><given-names>Christopher V</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-2763-3938</contrib-id><email>cvgabel@bu.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05qwgg493</institution-id><institution>Department of Pharmacology, Physiology and Biophysics, Chobanian &amp; Avedisian School of Medicine, Boston University</institution></institution-wrap><addr-line><named-content content-type="city">Boston</named-content></addr-line><country>United States</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04t5xt781</institution-id><institution>Department of Bioengineering, Northeastern University</institution></institution-wrap><addr-line><named-content content-type="city">Boston</named-content></addr-line><country>United States</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05qwgg493</institution-id><institution>Neurophotonics Center, Boston University</institution></institution-wrap><addr-line><named-content content-type="city">Boston</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Cochella</surname><given-names>Luisa</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00za53h95</institution-id><institution>Johns Hopkins University</institution></institution-wrap><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Sengupta</surname><given-names>Piali</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05abbep66</institution-id><institution>Brandeis University</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><pub-date publication-format="electronic" date-type="publication"><day>09</day><month>02</month><year>2024</year></pub-date><pub-date pub-type="collection"><year>2024</year></pub-date><volume>13</volume><elocation-id>e86478</elocation-id><history><date date-type="received" iso-8601-date="2023-01-28"><day>28</day><month>01</month><year>2023</year></date><date date-type="accepted" iso-8601-date="2023-11-17"><day>17</day><month>11</month><year>2023</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint at bioRxiv.</event-desc><date date-type="preprint" iso-8601-date="2023-03-06"><day>06</day><month>03</month><year>2023</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2023.03.05.531166"/></event></pub-history><permissions><copyright-statement>© 2024, Yadav et al</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>Yadav et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-86478-v1.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-86478-figures-v1.pdf"/><abstract><p>Cellular metabolism plays an essential role in the regrowth and regeneration of a neuron following physical injury. Yet, our knowledge of the specific metabolic pathways that are beneficial to neuron regeneration remains sparse. Previously, we have shown that modulation of O-linked β-N-acetylglucosamine (O-GlcNAc) signaling, a ubiquitous post-translational modification that acts as a cellular nutrient sensor, can significantly enhance in vivo neuron regeneration. Here, we define the specific metabolic pathway by which O-GlcNAc transferase (<italic>ogt-1</italic>) loss of function mediates increased regenerative outgrowth. Performing in vivo laser axotomy and measuring subsequent regeneration of individual neurons in <italic>C. elegans</italic>, we find that glycolysis, serine synthesis pathway (SSP), one-carbon metabolism (OCM), and the downstream transsulfuration metabolic pathway (TSP) are all essential in this process. The regenerative effects of <italic>ogt-1</italic> mutation are abrogated by genetic and/or pharmacological disruption of OCM and the SSP linking OCM to glycolysis. Testing downstream branches of this pathway, we find that enhanced regeneration is dependent only on the vitamin B12 independent shunt pathway. These results are further supported by RNA sequencing that reveals dramatic transcriptional changes by the <italic>ogt-1</italic> mutation, in the genes involved in glycolysis, OCM, TSP, and ATP metabolism. Strikingly, the beneficial effects of the <italic>ogt-1</italic> mutation can be recapitulated by simple metabolic supplementation of the OCM metabolite methionine in wild-type animals. Taken together, these data unearth the metabolic pathways involved in the increased regenerative capacity of a damaged neuron in <italic>ogt-1</italic> animals and highlight the therapeutic possibilities of OCM and its related pathways in the treatment of neuronal injury.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>neuron regeneration</kwd><kwd>cell metabolism</kwd><kwd>one-carbon metabolism</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd><italic>C. elegans</italic></kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100021045</institution-id><institution>Massachusetts Department of Public Health</institution></institution-wrap></funding-source><award-id>Massachusetts Spinal Cord Injury Cure Research Program, INTF3110HH2191525007</award-id><principal-award-recipient><name><surname>Yadav</surname><given-names>Dilip Kumar</given-names></name><name><surname>Chang</surname><given-names>Andrew C</given-names></name><name><surname>Gabel</surname><given-names>Christopher V</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>R56NS128413</award-id><principal-award-recipient><name><surname>Grooms</surname><given-names>Noa WF</given-names></name><name><surname>Chung</surname><given-names>Samuel H</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>The specific metabolic pathways that increase neuron regeneration in <italic>ogt-1</italic> mutant <italic>C. elegans</italic> following in vivo laser axotomy, highlighting the potential power for such metabolic targets in the treatment of neuronal injury.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>To regenerate efficiently, a damaged neuron must undergo molecular and metabolic rearrangement to induce and endure a range of complex cellular processes (<xref ref-type="bibr" rid="bib43">Mahar and Cavalli, 2018</xref>; <xref ref-type="bibr" rid="bib58">Taub et al., 2018</xref>; <xref ref-type="bibr" rid="bib70">Yang et al., 2020</xref>). These processes are extremely metabolically challenging, energy demanding, and critical for the regenerative capacity of a neuron (<xref ref-type="bibr" rid="bib5">Byrne et al., 2014</xref>; <xref ref-type="bibr" rid="bib7">Cartoni et al., 2016</xref>; <xref ref-type="bibr" rid="bib24">He and Jin, 2016</xref>; <xref ref-type="bibr" rid="bib70">Yang et al., 2020</xref>). The importance of metabolic pathways, particularly in neuronal regeneration including the insulin-signaling pathway, energy metabolism, and mitochondrial function have been reported in research articles by several groups (<xref ref-type="bibr" rid="bib5">Byrne et al., 2014</xref>; <xref ref-type="bibr" rid="bib7">Cartoni et al., 2016</xref>; <xref ref-type="bibr" rid="bib22">Han et al., 2016</xref>; <xref ref-type="bibr" rid="bib23">Han et al., 2020</xref>). Nonetheless, critical questions remain as to the alterations in cellular metabolism and metabolic pathways linked with energy production in a damaged and regenerating neurons and how these processes might be exploited for therapeutic benefits.</p><p>In a previous study our group demonstrated that perturbation in O-GlcNAc signaling, a post-translational modification of serine and threonine that is known to act as a nutrient sensor, substantially increased axonal regeneration in <italic>Caenorhabditis elegans</italic> (<italic>C. elegans</italic>) (<xref ref-type="bibr" rid="bib58">Taub et al., 2018</xref>). Carrying out in vivo laser axotomies, we demonstrated that a reduction of O-GlcNAc levels, due to deletion mutation of the <italic>ogt-1</italic>, induces the AKT-1 branch of the insulin-signaling pathway to utilize glycolysis and significantly enhanced neuronal regeneration. Inhibition of the glycolytic pathway through RNAi knockdown of phosphoglycerate kinase (<italic>pgk-1</italic>) or loss of function of phosphofructokinase-1.1 (<italic>pfk-1.1</italic>) specifically suppressed <italic>ogt-1</italic> enhanced regeneration but did not alter wild-type regeneration (<xref ref-type="bibr" rid="bib58">Taub et al., 2018</xref>). Furthermore, supplementation with glucose in wild-type animals is sufficient to increase axonal regeneration after axotomy (<xref ref-type="bibr" rid="bib58">Taub et al., 2018</xref>). These observations established the significance of glycolytic metabolism to control and enhance neuronal regeneration.</p><p>To date key questions remain as to what specific metabolic pathways are stimulated in the <italic>ogt-1</italic> mutant background and what cellular processes are augmented to increase regenerative capacity. Numerous reports suggest that increased glycolysis averts metabolic flux toward OCMto regulate numerous biological processes including molecular reprogramming, immunological functions as well as neuronal development and function (<xref ref-type="bibr" rid="bib25">Iskandar et al., 2010</xref>; <xref ref-type="bibr" rid="bib33">Konno et al., 2017</xref>; <xref ref-type="bibr" rid="bib73">Yu et al., 2019b</xref>). In addition, studies have reported the importance of metabolic amendments of OCM, the SSP and the TSP in neuronal development, structure, function, and regeneration (<xref ref-type="bibr" rid="bib25">Iskandar et al., 2010</xref>; <xref ref-type="bibr" rid="bib3">Bonvento and Bolaños, 2021</xref>; <xref ref-type="bibr" rid="bib35">Lam et al., 2021</xref>; <xref ref-type="bibr" rid="bib8">Chen et al., 2022</xref>). Measuring neuronal regeneration in <italic>C. elegans</italic> following laser axotomy under genetic and pharmacological perturbations of metabolic pathways, we demonstrate that both functional OCM and glycolytic flux towards OCM <italic>via</italic> the SSP are essential for enhanced regeneration in <italic>ogt-1</italic> animals. From there, we observed that metabolic pathways from OCM through the TSP, that result in cystathionine metabolism into Acetyl-CoA <italic>via</italic> the vitamin B12 independent shunt pathway, is also critical. Taken together our results illustrate how <italic>ogt-1</italic> acts as a major regulator of metabolic pathways to orchestrate and maximize the regenerative response in a damaged neuron and suggest that OCM and its related pathways could serve as a potent neurotherapeutic target.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Blocking the hexosamine biosynthesis pathway (HBP) is adequate to phenocopy the enhanced neuronal regeneration of <italic>ogt-1</italic> animals</title><p>Following our previous study, <xref ref-type="bibr" rid="bib58">Taub et al., 2018</xref>, we sought to confirm and expand on our finding that <italic>ogt-1</italic> loss of function mutation enhances neuron regeneration through modulation of glycolysis. Performing laser axotomy on individual neurons in vivo and measuring regenerative outgrowth after 24 hr, we found that either <italic>ogt-1</italic> (deletion, ok1474 strain crossed with zdis-5) mutation or the enzymatically <italic>ogt-1</italic> dead allele (ogt-1-dAl; OG1135 strain crossed with zdis-5) equally increase neuronal regeneration following laser axotomy of mechanosensory neurons in <italic>C. elegans</italic> (<xref ref-type="fig" rid="fig1">Figure 1A–B</xref>, <xref ref-type="supplementary-material" rid="fig1sdata1">Figure 1—source data 1</xref>). Reduced O-GlcNAc levels due to the loss of function of <italic>ogt-1</italic> will effectively block the metabolic flux into the HBP, diverting metabolites towards glycolysis (<xref ref-type="bibr" rid="bib71">Yi et al., 2012</xref>; <xref ref-type="bibr" rid="bib27">Jóźwiak and Forma, 2014</xref>; <xref ref-type="bibr" rid="bib32">Kim et al., 2018</xref>). To investigate if blocking the HBP is sufficient to enhanced neuronal regeneration in the wild-type worms, we knocked down Glutamine-Fructose 6-phosphate Amino Transferase (<italic>gfat-1</italic> and <italic>gfat-2</italic>) using neuron-specific RNAi. <italic>gfat-1</italic> and <italic>gfat-2</italic>, orthologs of the human glutamine-fructose-6-phosphate transaminase 1 (<italic>GFPT1</italic>), catalyzes the very first and rate limiting step of HBP (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). We found that knocking down either <italic>gfat-1</italic> or <italic>gfat-2</italic> in the wild type worms, significantly increase the regeneration of mechanosensory neurons, similar to <italic>ogt-1</italic> loss of function, (<xref ref-type="fig" rid="fig1">Figure 1C</xref>, <xref ref-type="supplementary-material" rid="fig1sdata1">Figure 1—source data 1</xref>).</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Blocking the HBS pathway is sufficient to phenocopy the neuronal regeneration of O-GlcNAc transferase (<italic>ogt-1)</italic> animals.</title><p>(<bold>A</bold>) Schematic diagram showing the hexosamine synthesis pathway linking glycolysis and <italic>ogt-1</italic> function, and the representative image of the effect of <italic>ogt-1</italic> mutation and <italic>gfat-1/gfat-2</italic> and <italic>pyk-1</italic> RNAi knockdown on regenerating neurons imaged at 24 hr (yellow arrow indicates the proximal and red arrow indicated distal point of injury). (<bold>B</bold>) 24 hr regeneration data of wild-type (WT), <italic>ogt-1</italic> deletion mutant (OGT-1) and <italic>ogt-1</italic> dead allele (OGT-1-dAl, strain OG1135) worms on nematode growth media (NGM) after 24 hr. (<bold>C</bold>) 24 h regeneration data of control and <italic>gfat-1/gfat-2</italic> RNAi experiments. (<bold>D</bold>) 24 hr regeneration data of control and RNAi experiment for <italic>pyk-1</italic> and <italic>atp-3</italic>. (<bold>E</bold>) pyk-1 activity measured in WT and <italic>ogt-1</italic> animal whole lysate using pyruvate kinase (PK) Assay Kit (Abcam, cat# Ab83432). (<bold>F</bold>) Relative amount of ATP measured using a fluorescence resonance energy transfer (FRET)-based ATP sensor. OGT-1-dAl; ogt-1-dead Allele, AU; Arbitrary Unit, scale bar = ~10 μM, all data shown in ± SEM, analytical methods student t-test and one-way ANOVA, *p &lt;0.05, **p &lt;0.01, ***p &lt;0.001.</p><p><supplementary-material id="fig1sdata1"><label>Figure 1—source data 1.</label><caption><title>Regeneration lengths measured with ImageJ/FIJI and ATP levels measured using ATP sensor data for <xref ref-type="fig" rid="fig1">Figure 1</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-86478-fig1-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-86478-fig1-v1.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>CeNGEN pyk expression pattern in the neurons of <italic>C. elegans</italic>, ATP levels and ATP utilization in Wildtype and <italic>ogt-1</italic> animals.</title><p>(<bold>A</bold>) <italic>pyk-1</italic> expression analysis in neuronal cell, single cell neuronal RNA sequencing (RNA-seq) data from worm base (<ext-link ext-link-type="uri" xlink:href="https://wormbase.org/species/c_elegans/gene/WBGene00009126">https://wormbase.org/species/c_elegans/gene/WBGene00009126</ext-link>#0-9fce6b37d81-10) was used to generate the image. (<bold>B</bold>) <italic>pyk-2</italic> expression analysis in neuronal cell, as for <italic>pyk-1</italic>. (<bold>C</bold>) Relative amount of ATP measured using ATP assay kit (Abcam, cat# Ab83355) in whole worm lysate. (<bold>D</bold>) Relative amount of pyrophosphate (PPi) measured using pyrophosphate assay kit (Abcam, cat# Ab112155) in whole worm lysate. All data shown in ± SEM, analytical methods, student t-test was used *p &lt;0.05, **p &lt;0.01, ***p &lt;0.001.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-86478-fig1-figsupp1-v1.tif"/></fig></fig-group><p>Earlier we reported that the regenerative effects of <italic>ogt-1</italic> were dependent on numerous elements of the glycolytic pathway. In this study, we tested pyruvate kinase (PK), PKM1/2 (encoded by <italic>pyk-1</italic> in <italic>C. elegans</italic>) which catalyzes the final step of glycolysis and is known to be regulated by O-GlcNAc levels (<xref ref-type="bibr" rid="bib64">Wang et al., 2017</xref>; <xref ref-type="bibr" rid="bib1">Bacigalupa et al., 2018</xref>; <xref ref-type="bibr" rid="bib72">Yu et al., 2019a</xref>). <italic>C. elegans</italic> has two orthologs of mammalian PK, <italic>pyk-1</italic> and <italic>pyk-2,</italic> with <italic>pyk-1</italic> expression primarily in neurons including the mechanosensory neurons ALM and PLM and <italic>pyk-2</italic> showing limited neuronal expression (<xref ref-type="bibr" rid="bib21">Hammarlund et al., 2018</xref>; <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref> and <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1B</xref>). Interestingly, we found that the knock down of <italic>pyk-1, via</italic> neuron-specific RNAi, does not affect the enhanced regeneration in the <italic>ogt-1</italic> mutant but significantly increases regeneration in WT (<xref ref-type="fig" rid="fig1">Figure 1A and D</xref>, <xref ref-type="supplementary-material" rid="fig1sdata1">Figure 1—source data 1</xref>), to levels similar to that of <italic>ogt-1</italic>. Furthermore, performing <italic>pyk-1</italic> activity assay in whole worm lysate we observed that over all <italic>pyk-1</italic> activity is significantly down in <italic>ogt-1</italic> worms (<xref ref-type="fig" rid="fig1">Figure 1E</xref>). These results suggest the final step of glycolysis, mediated by PYK-1, is not in fact involved in the enhanced regeneration of the <italic>ogt-1</italic> animals.</p><p>To investigate if energy production is critical for enhanced regeneration in <italic>ogt-1</italic> mutant animals, we performed neuron-specific RNAi knockdown of <italic>atp-3</italic>, an ortholog of human ATP5PO (ATP synthase peripheral stalk subunit OSCP) predicted to have proton-transporting ATP synthase activity. <italic>atp-3</italic> knockdown abrogated the <italic>ogt-1</italic>-mediated enhanced regeneration but had no effect on regeneration in WT (<xref ref-type="fig" rid="fig1">Figure 1D</xref>, <xref ref-type="supplementary-material" rid="fig1sdata1">Figure 1—source data 1</xref>). This is consistent with a critical role of ATP production in the enhanced regeneration of <italic>ogt-1</italic>. However, these effects did not translate to whole animal ATP level measurements. Employing a FRET-based transgenic fluorescence ATP sensor (as described earlier in <xref ref-type="bibr" rid="bib53">Soto et al., 2020</xref>; <xref ref-type="fig" rid="fig1">Figure 1F</xref>, <xref ref-type="supplementary-material" rid="fig1sdata1">Figure 1—source data 1</xref>) as well as ATP measurements in whole worm lysate, we found that ATP levels were significantly lower in <italic>ogt-1</italic> than WT worms (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1C</xref>). In addition, we assessed the ATP utilization from whole animals by measuring the pyrophosphate (PPi) levels as an indirect indication of ATP utilization but found no measurable difference between WT and <italic>ogt-1</italic> worms (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1D</xref>). Taken as a whole, these results infer that metabolic flux modulation through the majority of the glycolytic pathway and neuron-specific ATP production is important for <italic>ogt-1-</italic>mediated enhanced regeneration, but a complex interaction of metabolic pathways beyond that of canonical glycolysis may be involved specifically within the damaged and regenerating neurons.</p></sec><sec id="s2-2"><title>Gene expression analysis reveals the involvement of OCM and its offshoot pathways in enhanced neuron regeneration in <italic>ogt-1</italic> animals</title><p>To identify additional genes and pathways involved in the enhanced regeneration of the <italic>ogt-1</italic> background, we took an unbiased approach measuring differential gene expression <italic>via</italic> RNA-seq analysis in WT and <italic>ogt-1</italic> mutants. We first executed RNA-seq analysis from RNA isolated from whole animals and identified a substantial number of differentially expressed genes (DEGs) in <italic>ogt-1</italic> compared to WT (<xref ref-type="fig" rid="fig2">Figure 2A</xref>, <xref ref-type="supplementary-material" rid="fig2sdata1">Figure 2—source data 1</xref>). Gene ontology (GO) and KEGG pathway classification analysis of DEGs identified metabolic processes such as carbohydrates, lipids, amino acids, and nucleotide metabolism as the most enriched biological processes (<xref ref-type="fig" rid="fig2">Figure 2B–C</xref>, <xref ref-type="supplementary-material" rid="fig2sdata1">Figure 2—source data 1</xref>). In addition, cell membrane, cargo transport, nutrient reservoir, and energy metabolism are also enriched in <italic>ogt-1</italic> (<xref ref-type="fig" rid="fig2">Figure 2B–C</xref>, <xref ref-type="supplementary-material" rid="fig2sdata1">Figure 2—source data 1</xref>). KEGG metabolic pathway enrichment analysis revealed the enrichment of xenobiotics, drug metabolism along with glutathione metabolism, energy metabolism, amino acid, and nitrogen metabolic pathways (<xref ref-type="fig" rid="fig2">Figure 2D</xref>, <xref ref-type="supplementary-material" rid="fig2sdata1">Figure 2—source data 1</xref>). GO molecular function analysis highlights the nutrient reservoir, glutathione, and s-adenosyl methionine (SAM) dependent molecular functions (<xref ref-type="fig" rid="fig2">Figure 2E</xref>, <xref ref-type="supplementary-material" rid="fig2sdata1">Figure 2—source data 1</xref>). The enrichment of amino acid, nucleotide, glutathione, and SAM-dependent metabolic pathways indicate a possible role of OCM and its offshoot pathways in <italic>ogt-1</italic> mutant mediated regeneration.</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>RNA sequencing (RNA-seq) data analysis suggests important role of one-carbon metabolism (OCM) and related pathways in O-GlcNAc transferase (<italic>ogt-1)-</italic>mediated neuronal regeneration.</title><p>(<bold>A</bold>) A scatter plot of differentially expressed genes (DEGs) identified in RNA-seq between wild-type (WT) and <italic>ogt-1</italic> mutants. (<bold>B</bold>) Gene Ontology (GO) classification of DEGs in WT-vs-<italic>ogt-1</italic>. (<bold>C</bold>) KEGG pathway classification of DEGs in WT-vs-<italic>ogt-1</italic>. (<bold>D</bold>) KEGG pathway enrichment bubble plot of DEGs. (<bold>E</bold>) Enrichment bubble plot of GO molecular function analysis DEGs. (<bold>F</bold>) GO analysis of DEGs identified in neuron-specific RNA-seq between WT and <italic>ogt-1</italic> mutant (FDR0.1). (<bold>G</bold>) qRT-PCR of selected genes involved in one-carbon metabolism (OCM) (<italic>folr-1, metr-1, and sams-1</italic>) and nucleic acid methyltransferases and demethylases (<italic>damt-1 and nmad-2</italic>). All data shown ± SEM, Student t-test; *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001.</p><p><supplementary-material id="fig2sdata1"><label>Figure 2—source data 1.</label><caption><title>List of DEGs, GO and KEGG enrichment analysis of from whole body RNAseq data.</title></caption><media mimetype="application" mime-subtype="xls" xlink:href="elife-86478-fig2-data1-v1.xls"/></supplementary-material></p><p><supplementary-material id="fig2sdata2"><label>Figure 2—source data 2.</label><caption><title>List of DEGs, genes showing 2 fold expression changes and GO enrichment analysis form neuronal RNAseq Data.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-86478-fig2-data2-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-86478-fig2-v1.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>FACs shorting, Neuronal RNAseq DEGs, Gene Ontology (GO) pathways analysis and list of top 50 DEGs.</title><p>(<bold>A</bold>) Representative image of fluorescence-activated cell sorting (FACs) sorting for GFP tagged neuronal cells used for RNA isolation and RNA sequencing (RNA-seq) analysis. GFP control (left), wild type (middle), and <italic>ogt-1</italic> mutant (right) worms, respectively. (<bold>B</bold>) Volcano plot for differentially expressed genes (DEGs) FDR0.05. (<bold>C</bold>) Gene Ontology (GO) analysis of twofold up-regulated DEGs in WT-vs-<italic>ogt-1</italic> (FDR0.1) (<bold>D</bold>) GO analysis of twofold down regulated DEGs in WT-vs-<italic>ogt-1</italic> (FDR0.1). (<bold>E</bold>) List of top 50 up-regulated genes, and (<bold>F</bold>) top 50 down-regulated genes and their function, in <italic>ogt-1</italic> animals, identified in neuron-specific RNA-seq.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-86478-fig2-figsupp1-v1.tif"/></fig><fig id="fig2s2" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 2.</label><caption><title>Metabolic Pathway Analysis using DAVID from neuronal differentially expressed genes from neuronal RNAseq.</title><p>(<bold>A</bold>) Visualization of metabolic pathway enriched in differentially expressed genes (FDR0.1) identified in neuron-specific RNA sequencing (RNA-seq) analysis using ‘DAVID Metabolic Pathway Analysis’ tool. Top highlighted pathways are glycolysis (blue); lipid metabolism (green); nucleotide metabolism (red); serine synthesis pathway (light yellow); and one-carbon metabolism (OCM) and related pathways (dark yellow), respectively. (<bold>B</bold>) Pathway analysis of co-factor mediated biosynthesis of differentially expressed genes (FDR0.1) identified in neuron-specific RNA-seq analysis using the ‘DAVID Biosynthesis of Cofactors Analysis’ tool. Most affected pathways (green highlighted) include those related to OCM (folate, methionine, and SAM metabolism); Transsulfuration pathway (Cystein and Glutathione metabolism); and ATP production.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-86478-fig2-figsupp2-v1.tif"/></fig></fig-group><p>To further investigate if OCM and its related pathways are influenced by <italic>ogt-1</italic> mutation specifically within neuronal cells, we performed RNA-seq analysis in the RNA samples isolated from FACs (Fluorescence-activated cell sorting) sorted neuronal cells in WT and <italic>ogt-1</italic> worms (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A</xref>). Neuron-specific RNA-seq analysis identified a significant number of DEGs (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1B</xref>, <xref ref-type="supplementary-material" rid="fig2sdata2">Figure 2—source data 2</xref>). Interestingly, we did find that genes linked to HBP and glycolysis such as <italic>gaft-1/gfat-2</italic> and <italic>pyk-1</italic> were differentially regulated in our neuron-specific RNA-seq data (<xref ref-type="supplementary-material" rid="fig2sdata2">Figure 2—source data 2</xref>). As with whole worm analysis, GO pathway analysis of neuron-specific DEGs identified metabolic processes such as cellular, macromolecule, nitrogen compound, nucleic acid metabolism, <italic>etc</italic>. (<xref ref-type="fig" rid="fig2">Figure 2F</xref>, <xref ref-type="supplementary-material" rid="fig2sdata2">Figure 2—source data 2</xref>). GO analysis of twofold up-regulated genes revealed neuron-specific pathways as anticipated (neuronal perception, chemical and olfactory perception, synapses, <italic>etc.</italic>) along with carbohydrate and polysaccharide metabolic pathways (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1C</xref>, <xref ref-type="supplementary-material" rid="fig2sdata2">Figure 2—source data 2</xref>), while twofold down-regulated genes included biological processes like meiosis, mitosis, gamete/germ cell production and maturation, reproduction, cell cycle, nuclear division, and embryonic developments, <italic>etc</italic>. which are expected to be down regulated in the neuronal tissue (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1D</xref>, <xref ref-type="supplementary-material" rid="fig2sdata2">Figure 2—source data 2</xref>). Our top 50 up and down-regulated genes (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1E</xref> and <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1F</xref>) include important genes regulated by <italic>daf-2</italic> and <italic>daf-16</italic> which have been reported to play a critical role in adult neuron function and regeneration (<xref ref-type="bibr" rid="bib28">Kaletsky et al., 2016</xref>). In addition, other important genes involve in metabolism, epigenetic modification, and ATP metabolism are also enriched. Employing whole animal qRT-PCR, we further confirmed that <italic>folr-1, metr-1, sams-1,</italic> important genes for OCM, were significantly up-regulated in the <italic>ogt-1</italic> background compared to WT (<xref ref-type="fig" rid="fig2">Figure 2G</xref>). While DNA methyltransferase (<italic>damt-1</italic>) was significantly down regulated and DNA demethylases (<italic>nmad-1</italic>) was unchanged (<xref ref-type="fig" rid="fig2">Figure 2G</xref>), Further bioinformatic analysis of neuron-specific DEGs using the Functional Annotation Tool ‘DAVID Bioinformatics Resources’ revealed the enrichment of metabolic pathways such as glycolysis, lipid metabolism along with SSP, OCM, amino acid, nucleotide, and nitrogen compound metabolism, <italic>etc</italic>. (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2A</xref>). While biosynthesis of cofactor analysis specified enrichment of Folate, Methionine, and SAM metabolism cycles, glutathione metabolism, and ATP synthesis pathways (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2B</xref>). Taken together, the results of our unbiased high throughput gene expression analysis strongly indicate the involvement of OCM and its offshoot pathways in the increased neuronal regeneration in <italic>ogt-1</italic> mutant animals.</p></sec><sec id="s2-3"><title>Functional OCM and SSP are indispensable for enhanced regeneration in <italic>ogt-1</italic> animals</title><p>Following the result of our gene expression analysis we sought to functionally validate the importance of the OCM and related pathways in neuronal regeneration in <italic>ogt-1</italic> worms. We first focused on the SSP as it metabolically connects glycolysis with OCM (<xref ref-type="fig" rid="fig3">Figure 3A</xref>; <xref ref-type="bibr" rid="bib73">Yu et al., 2019b</xref>). NCT502 (MCE HY-117240) is a chemical agent reported to inhibits the mammalian phosphoglycerate dehydrogenase (PHGDH) enzyme, which catalyzes the first and rate-limiting step of serine biosynthesis (<xref ref-type="bibr" rid="bib57">Tabatabaie et al., 2010</xref>; <xref ref-type="bibr" rid="bib76">Zogg, 2014</xref>; <xref ref-type="bibr" rid="bib47">Pacold et al., 2016</xref>). Applied to <italic>C. elegans</italic>, NCT502 abrogated the effect of <italic>ogt-1</italic> mutation on neuronal regeneration but significantly increased the regeneration in WT worms (<xref ref-type="fig" rid="fig3">Figure 3B</xref>, <xref ref-type="supplementary-material" rid="fig3sdata1">Figure 3—source data 1</xref>). In addition, we observe that the supplementation of L-serine, the final product of SSP, which feeds into OCM, rescued the abrogative effect of NCT502 in <italic>ogt-1</italic> (<xref ref-type="fig" rid="fig3">Figure 3B</xref>, <xref ref-type="supplementary-material" rid="fig3sdata1">Figure 3—source data 1</xref>). Previously we found that AKT kinase, <italic>akt-1,</italic> activity, plays an important role in <italic>ogt-1</italic> regeneration, <italic>akt-1</italic> mutation blocked the enhanced regeneration of <italic>ogt-1,</italic> while gain of function <italic>akt-1(++</italic>) phenocopied <italic>ogt-1</italic> effect (<xref ref-type="bibr" rid="bib58">Taub et al., 2018</xref>). Interestingly, NCT502 blocked the enhanced regeneration <italic>in ogt-1(-); akt-1(++</italic>) worms (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A</xref>, <xref ref-type="supplementary-material" rid="fig3s1sdata1">Figure 3—figure supplement 1—source data 1</xref>); and serine supplementation rescued the enhanced regeneration that is eliminated in <italic>akt-1(-);ogt-1(-</italic>) worms (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A</xref>, <xref ref-type="supplementary-material" rid="fig3s1sdata1">Figure 3—figure supplement 1—source data 1</xref>). Since NCT502 has not been earlier reported to be used in <italic>C. elegans</italic>, we also tested the effects of blocking SSP using RNAi gene knockdown. In concordance with NCT502 treatment, neuron-specific RNAi against C31C9.2 (termed as <italic>phgdh-1</italic>), the <italic>C. elegans</italic> ortholog of human PHGDH and target of NCT502, abrogated the effects of <italic>ogt-1</italic>-mediated regeneration, and significantly increased the regeneration in WT worms even beyond that of <italic>ogt-1</italic> worms (<xref ref-type="fig" rid="fig3">Figure 3C</xref>, <xref ref-type="supplementary-material" rid="fig3sdata1">Figure 3—source data 1</xref>). Interestingly, systemic RNAi knockdown against C31C9.2 (<italic>phgdh-1</italic>), that is ineffective in neurons, did not alter regeneration levels in <italic>ogt-1</italic> animals suggesting a neuron-specific mechanism. However, it did significantly increase regeneration in WT worms (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1B</xref>, <xref ref-type="supplementary-material" rid="fig3s1sdata2">Figure 3—figure supplement 1—source data 2</xref>). We further measured <italic>pyk-1</italic> activity in WT worms and found that it was significantly enhanced by NCT502 treatment (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1C</xref>) suggesting increased glycolytic activity upon blocking the SSP. Interestingly, we observed equally enhanced <italic>pyk-1</italic> activity in <italic>ogt-1</italic> worms with NCT502 treatment (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1D</xref>). These results demonstrate the importance of the SSP pathway in <italic>ogt-1-</italic>mediated enhanced neuron regeneration but suggest that in wild-type animals the reverse may be true and blocking SSP becomes beneficial.</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Functional one-carbon metabolism (OCM) and serine synthesis pathway (SSP) are essential for neuronal regeneration in O-GlcNAc transferase (<italic>ogt-1)</italic> worms.</title><p>(<bold>A</bold>) Schematic representation showing glycolysis and the SSP, along with representative images at 24 hr neuron regeneration in conditions blocking the SSP in <italic>ogt-1</italic> mutants using either neuron-specific RNAi or NCT502 drug (yellow arrow indicates the proximal and red arrow indicated distal point of injury). (<bold>B</bold>) Effect of NCT502 drug and supplementation of serine on wild-type (WT) and <italic>ogt-1</italic> mutant 24 hr neuronal regeneration. (<bold>C</bold>) Effect of neuron-specific RNAi against <italic>C31C9.2</italic> (ortholog of human <italic>PHGDH</italic> gene) on WT and <italic>ogt-1</italic> mutant neuronal regeneration. (<bold>D</bold>) Schematic representation of the metabolic link between glycolysis and OCM via SSP, along with representative images of 24 hr neuron regeneration with different OCM gene mutations in <italic>ogt-1</italic> background (yellow arrow indicates the proximal and red arrow indicated distal point of injury). (<bold>E</bold>) Effects of <italic>metr-1</italic> and <italic>sams-1</italic> mutations on enhanced regeneration in <italic>ogt-1</italic> worms. (<bold>F</bold>) Effects of methionine supplementation on regeneration in WT, <italic>ogt-1</italic> animals, and on the <italic>phgdh-1</italic> inhibitor drug NCT502. (<bold>G</bold>) Schematic representation of OCM metabolite SAM usage in lipogenesis and transmethylation, along with representative images of neuron regeneration when they are blocked (yellow arrow indicates the proximal and red arrow indicated distal point of injury). (<bold>H</bold>) 24 hr neuron regeneration with choline supplementation in <italic>ogt-1/sams-1</italic> dual mutant and neuron-specific RNAi against <italic>pmt-1</italic>. (<bold>I</bold>) 24 hr neuron regeneration when blocking methyltransferases by neuron-specific RNAi (<italic>set-2, set-11, set-16,</italic> and <italic>set-17</italic>) in WT and <italic>ogt-1</italic> animals. scale bar = ~10 μM, all data shown in ± SEM, one-way ANOVA *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001.</p><p><supplementary-material id="fig3sdata1"><label>Figure 3—source data 1.</label><caption><title>Regeneration lengths measured with ImageJ/FIJI data for <xref ref-type="fig" rid="fig3">Figure 3</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-86478-fig3-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-86478-fig3-v1.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>Effect of Serine, NCT502 and methionine supplementation on Neuronal regeneration and pyk-1 activity, systemic RNAi of C31C9.2 and Expression patter important OCM genes from Neuronal RNAseq.</title><p>(<bold>A</bold>) The effects of NCT502 mediated inhibition of the serine synthesis pathway and serine supplementation on regeneration in <italic>akt-1</italic> (gain of function) and <italic>akt-1</italic> (loss of function) mutations in the O-GlcNAc transferase (<italic>ogt-1)</italic> background. (<bold>B</bold>) 24 hr neuron regeneration with systemic RNAi knockdown against C31C9.2 (ortholog of human PHGDH). (<bold>C</bold>) <italic>pyk-1</italic> activity in wild-type (WT) worms grown with and without NCT502 treatment. (<bold>D</bold>) <italic>pyk-1</italic> activity in WT and <italic>ogt-1</italic> worms grown with NCT502 treatment. (<bold>E</bold>) The effect of different doses of methionine supplementation on 24 hr neuron regeneration in WT worms. (<bold>F</bold>) Expression, patterns of selected genes involved in OCM (<italic>sams-1, metr-1, folr-1, and mthf-1</italic>), Transmethylation (<italic>damt-1 and nmad-1</italic>), and lipogenesis (<italic>pmt-1 and pmt-2</italic>) in neuronal cell RNA sequencing (RNA-seq) analysis which passed FDR 0.1. All data shown in ± SEM, analytical methods; student t-test and one-way ANOVA were used; ns, no significance; *p &lt;0.05, **p &lt;0.01, ***p&lt;0.001.</p><p><supplementary-material id="fig3s1sdata1"><label>Figure 3—figure supplement 1—source data 1.</label><caption><title>Regeneration lengths measured with ImageJ/FIJI data for <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-86478-fig3-figsupp1-data1-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig3s1sdata2"><label>Figure 3—figure supplement 1—source data 2.</label><caption><title>Regeneration lengths measured with ImageJ/FIJI data for <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1B</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-86478-fig3-figsupp1-data2-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig3s1sdata3"><label>Figure 3—figure supplement 1—source data 3.</label><caption><title>Regeneration lengths measured with ImageJ/FIJI data for <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1E</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-86478-fig3-figsupp1-data3-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-86478-fig3-figsupp1-v1.tif"/></fig></fig-group><p>To test the importance of OCM in <italic>ogt-1-</italic>mediated regeneration directly, we tested mutations of methionine synthase (<italic>metr-1</italic>), an ortholog of the human MTR gene and s-adenosyl methionine synthetase-1 (<italic>sams-1</italic>), an ortholog of human MAT1A and MAT2A genes, in the <italic>ogt-1</italic> background (<italic>ogt-1;metr-1,</italic> and <italic>ogt-1;sams-1</italic>) (<xref ref-type="fig" rid="fig3">Figure 3D</xref>). Both mutations abrogated the enhanced regeneration in <italic>ogt-1</italic> animals but had no significant effect on WT regeneration (<xref ref-type="fig" rid="fig3">Figure 3E</xref>, <xref ref-type="supplementary-material" rid="fig3sdata1">Figure 3—source data 1</xref>). Methionine is an important metabolite of the OCM cycle and its supplementation increases OCM flux (<xref ref-type="bibr" rid="bib45">Miousse et al., 2017</xref>; <xref ref-type="bibr" rid="bib51">Sanderson et al., 2019</xref>; <xref ref-type="bibr" rid="bib38">Ligthart-Melis et al., 2020</xref>). Methionine supplementation significantly increased the regeneration in WT worms but had no additional effect on <italic>ogt-1</italic> worms (<xref ref-type="fig" rid="fig3">Figure 3F</xref>, <xref ref-type="supplementary-material" rid="fig3sdata1">Figure 3—source data 1</xref>, and <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1E</xref>, <xref ref-type="supplementary-material" rid="fig3s1sdata3">Figure 3—figure supplement 1—source data 3</xref>). Nor did it alter the effects of blocking the SSP in either WT or <italic>ogt-1</italic> animals (<xref ref-type="fig" rid="fig3">Figure 3F</xref>, <xref ref-type="supplementary-material" rid="fig3sdata1">Figure 3—source data 1</xref>) which may be in part due to the requirement of serine for normal OCM progression downstream (<xref ref-type="bibr" rid="bib69">Yang and Vousden, 2016</xref>; <xref ref-type="bibr" rid="bib11">Clare et al., 2019</xref>; <xref ref-type="bibr" rid="bib18">Geeraerts et al., 2021</xref>). SAM, a product of SAMS-1 and an important metabolite of OCM, mediates numerous cellular processes including several biosynthetic, post-translational modifications and epigenetic modifications of histones and nucleic acids for regulation of gene expression and metabolism, including glycolysis (<xref ref-type="bibr" rid="bib16">Ducker and Rabinowitz, 2017</xref>; <xref ref-type="bibr" rid="bib11">Clare et al., 2019</xref>). It participates in the Kennedy pathway to synthesize lipid (Phosphatidyl Choline) an important component of the cellular membrane (<xref ref-type="fig" rid="fig3">Figure 3G</xref>; <xref ref-type="bibr" rid="bib63">Walker, 2017</xref>). Phosphatidyl Choline can alternatively be synthesized from choline. However, we found that choline supplementation in <italic>ogt-1;sams-1</italic> dual mutant failed to rescue the effects of <italic>sams-1</italic> mutation (<xref ref-type="fig" rid="fig3">Figure 3H</xref>, <xref ref-type="supplementary-material" rid="fig3sdata1">Figure 3—source data 1</xref>). Furthermore, neuron-specific RNAi against phosphoethanolamine methyl transferase (<italic>pmt-1</italic>), involved in phosphatidyl choline biosynthesis from SAM, did not reduce <italic>ogt-1</italic>-mediated regeneration, although it did enhance the regeneration in WT worms (<xref ref-type="fig" rid="fig3">Figure 3H</xref>, <xref ref-type="supplementary-material" rid="fig3sdata1">Figure 3—source data 1</xref>). SAM also acts as a methyl doner for transmethylation reactions including histone modification. To test if the epigenetic modification of histones by histone methyltransferases play any role in <italic>ogt-1</italic> enhanced regeneration, we knocked down several reported H3K4 methyltransferase with known effects on H3K4 methylation and/or neuronal regeneration including <italic>set-2, set-11, set-16,</italic> and <italic>set-17</italic> (<xref ref-type="bibr" rid="bib62">Walker et al., 2011</xref>; <xref ref-type="bibr" rid="bib67">Wilson et al., 2020</xref>). Knocking down these methyltransferases had no significant effect on <italic>ogt-1-</italic>mediated enhanced regeneration but significantly increased regeneration in WT worms (<xref ref-type="fig" rid="fig3">Figure 3I</xref>, <xref ref-type="supplementary-material" rid="fig3sdata1">Figure 3—source data 1</xref>). RNA-seq analysis also showed that DNA methylases (<italic>damt-1</italic>) and demethylase (<italic>nmad-1</italic>) as well as <italic>pmt-1/pmt-2</italic>, required for Phosphatidyl Choline synthesis from SAM, were all relatively downregulated while OCM genes were relatively upregulated in neuronal tissue in <italic>ogt-1</italic> animals (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1F</xref>). Thus, while the functional OCM pathway mediated by MERT-1 and SAMS-1 is essential for <italic>ogt-1-</italic>mediated enhanced regeneration, these results suggest that it does not act through either lipogenesis or transmethylation pathways involved in epigenetic regulation.</p></sec><sec id="s2-4"><title>The TSP, an offshoot of OCM, is critical for enhanced neuronal regeneration in <italic>ogt-1</italic> animals</title><p>Our gene expression analysis revealed that OCM-related pathways such as glutathione and SAM metabolism are highly altered in <italic>ogt-1</italic> worms. We, therefore, tested the importance of the transsulfuration pathway in <italic>ogt-1</italic>-mediated regeneration (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). The transsulfuration pathway involves cysteine and cystathionine metabolism that is utilized in glutathione synthesis important for oxidative stress maintenance in neurons (<xref ref-type="bibr" rid="bib61">Vitvitsky et al., 2006</xref>; <xref ref-type="bibr" rid="bib52">Sbodio et al., 2019</xref>). Performing neuron-specific RNAi against glutathione synthetase (<italic>gss-1</italic>), an ortholog of GSS, we detected no effect on the enhanced regeneration in the <italic>ogt-1</italic> mutant background but significantly increased regeneration in WT (<xref ref-type="fig" rid="fig4">Figure 4B</xref>, <xref ref-type="supplementary-material" rid="fig4sdata1">Figure 4—source data 1</xref>). In a complimentary manor, supplementation with L-Glutathione (GHS) significantly decreased regeneration in <italic>ogt-1</italic> worms but had no effect on WT worms (<xref ref-type="fig" rid="fig4">Figure 4B</xref>, <xref ref-type="supplementary-material" rid="fig4sdata1">Figure 4—source data 1</xref>). By contrast, supplementation with L-cystathionine had no detectable effect on regeneration in <italic>ogt-1</italic> worms or WT (<xref ref-type="fig" rid="fig4">Figure 4C</xref>, <xref ref-type="supplementary-material" rid="fig4sdata1">Figure 4—source data 1</xref>) but rescued the effect of blocking SSP with NCT502 in <italic>ogt-1</italic> worms (<xref ref-type="fig" rid="fig4">Figure 4C</xref>, <xref ref-type="supplementary-material" rid="fig4sdata1">Figure 4—source data 1</xref>). These observations suggest that while the transsulfuration pathway is functionally involved in <italic>ogt-1-</italic>mediated enhanced regeneration it is not through glutathione synthesis.</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>The transsulfuration pathway (TSP) leading to acetyl-CoA production mediates enhanced regeneration in O-GlcNAc transferase (<italic>ogt-1)</italic> animals.</title><p>(<bold>A</bold>) Schematic representation of the transsulfuration pathway (TSP; shaded area) branch of OCM, along with supplementation with TSP metabolites L-cystathionine, Glutathione, and neuron-specific RNAi against Glutathione synthetase (<italic>gss-</italic>1) with its effect on 24 hr neuron regenerating neuron (representative images) (yellow arrow indicates the proximal and red arrow indicated distal point of injury). (<bold>B</bold>) Effects of GHS supplementation and neuronal RNAi knockdown against <italic>gss-1</italic> on neuronal regeneration in wild-type (WT) and <italic>ogt-1</italic> worms. (<bold>C</bold>) Effects of L-cystathionine supplementation on neuronal regeneration in WT and <italic>ogt-1</italic> worms, with or without SSP blocking by NCT502. (<bold>D</bold>) qRT-PCR of selected genes involved in transsulfuration (<italic>cth-1</italic> and <italic>cth-2</italic>), as well as the related downstream vitamin B12 dependent canonical pathways (<italic>pcca-1, pccb-1, mce-1, and mmcm-1</italic>) and the vitamin B12 independent Shunt pathway (<italic>acdh-1, ech-6, hach-1, hphd-1, and alh-8</italic>). (<bold>E</bold>) Schematic representation of the TSP metabolites L-Cystathionine metabolism into succinyl-CoA and acetyl-CoA <italic>via</italic> canonical and shunt pathway, respectively and genes involved with indicated mutants (<italic>acdh-1</italic> and <italic>mce-1</italic>) used in the study, along with a representative regenerating neuron image (yellow arrow indicates the proximal and red arrow indicated distal point of injury). (<bold>F</bold>) Effect of <italic>acdh-1</italic> and <italic>mce-1</italic> mutation in WT and <italic>ogt-1</italic> background on neuronal regeneration. (<bold>G</bold>) Effect of blocking lipid synthesis from acetyl CoA and ATP production on regeneration in WT and <italic>ogt-1</italic>. scale bar = ~10 μM, all data shown in ± SEM, analytical methods student t-test and one-way ANOVA were used *p &lt;0.05, **p &lt;0.01, ***p &lt;0.001 .</p><p><supplementary-material id="fig4sdata1"><label>Figure 4—source data 1.</label><caption><title>Regeneration lengths measured with ImageJ/FIJI data for <xref ref-type="fig" rid="fig4">Figure 4</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-86478-fig4-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-86478-fig4-v1.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>Expression patter important genes from TSP in Neuronal RNAseq data and effect of gene knock down of TSP and lipid metabolism.</title><p>(<bold>A</bold>) Expression patterns, of selected genes involved in vitamin B12 independent shunt pathway (<italic>acdh-1, each-6, hach-1, hphd-1, and alh-8</italic>) and vitamin B12 dependent canonical pathway (<italic>cth-1, pcca-1, pccb-1, mce-1, and mmc-1</italic>) downstream to transsulfuration pathway (TSP), in neuronal cell RNA sequencing (RNA-seq) analysis which passed FDR 0.1. (<bold>B</bold>) The effect on 24 hr neuron regeneration from neuron-specific RNAi knockdown of <italic>acdh-1</italic> and <italic>mce-1</italic> in <italic>ogt-1</italic> and wild-type (WT) worms. (<bold>C</bold>) The effect on 24 hr neuron regeneration from neuron-specific RNAi knockdown of <italic>cpt-2</italic> and <italic>acs-2</italic> in <italic>ogt-1</italic> and WT worms. All data shown in ± SEM, analytical methods; one-way ANOVA was used; ns, no significance; *p &lt;0.05, **p &lt;0.01, ***p &lt;0.001.</p><p><supplementary-material id="fig4s1sdata1"><label>Figure 4—figure supplement 1—source data 1.</label><caption><title>Regeneration lengths measured with ImageJ/FIJI data for <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1B</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-86478-fig4-figsupp1-data1-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig4s1sdata2"><label>Figure 4—figure supplement 1—source data 2.</label><caption><title>Regeneration lengths measured with ImageJ/FIJI data for <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1C</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-86478-fig4-figsupp1-data2-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-86478-fig4-figsupp1-v1.tif"/></fig></fig-group><p>Cystathionine can be further metabolized into succinyl-CoA or acetyl-CoA through either the vitamin B12 dependent canonical pathway or the vitamin B12 independent shunt pathways, respectively (<xref ref-type="bibr" rid="bib66">Watson et al., 2016</xref>; <xref ref-type="bibr" rid="bib19">Giese et al., 2020</xref>). Succinyl-CoA or acetyl-CoA can be further used for different metabolic processes or can enter the Krebs Cycle to produce ATP. Our neuronal cell-specific RNA-seq analysis revealed that genes involved in OCM (<italic>metr-1, sams-1, folr-1, mthf-1, etc</italic>.) (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1F</xref>), transsulfuration (<italic>cth-1</italic>) (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A</xref>), and the downstream vitamin B12 independent shunt pathway (<italic>acdh-1, ech-6, hach-1, hphd-1, and alh-8</italic>) were relatively upregulated (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A</xref>) in <italic>ogt-1</italic> animals, while genes involved in the vitamin B12 dependent canonical pathway (<italic>pcca-1, pccb-1, mce-1, and mmcm-1</italic>) were down regulated (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A</xref>). Likewise, performing qRT-PCR analysis against genes in these pathways, we found that genes involved in TSP (<italic>cth-1, cht-2</italic>) and in the vitamin B12 independent shunt pathway showed unidirectional upregulated expression in <italic>ogt-1</italic> (<xref ref-type="fig" rid="fig4">Figure 4D</xref>), while genes involved in the canonical vitamin B12 dependent pathway showed no clear trend in differential expression (<xref ref-type="fig" rid="fig4">Figure 4D</xref>).</p><p>To test the role of cystathionine metabolism through shunt and canonical pathways directly in neuronal regeneration, we generated double mutants with acyl-CoA dehydrogenase (<italic>acdh-1</italic>) that mediates the vitamin B12 independent shunt pathway, <italic>ogt-1;acdh-1,</italic> and methylmalonyl-CoA epimerase (<italic>mce-1</italic>) that mediates the vitamin B12 dependent canonical pathway <italic>ogt-1;mce-1</italic> (<xref ref-type="fig" rid="fig4">Figure 4E</xref>). The <italic>mce-1</italic> mutation had no effect on regeneration in either WT or the <italic>ogt-1</italic> background (<italic>ogt-1;mce-1</italic>) (<xref ref-type="fig" rid="fig4">Figure 4F</xref>, <xref ref-type="supplementary-material" rid="fig4sdata1">Figure 4—source data 1</xref>). However, while <italic>acdh-1</italic> mutation had no effect on WT regeneration, it selectively eliminated the enhanced regeneration of the <italic>ogt-1</italic> background (<italic>ogt-1;cdh-1</italic>) (<xref ref-type="fig" rid="fig4">Figure 4F</xref>, <xref ref-type="supplementary-material" rid="fig4sdata1">Figure 4—source data 1</xref>). These results were recapitulated using neuron-specific RNAi knockdown against <italic>acdh-1</italic> and <italic>mce-1</italic> in the <italic>ogt-1</italic> background (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1B</xref>, <xref ref-type="supplementary-material" rid="fig4s1sdata1">Figure 4—figure supplement 1—source data 1</xref>). Neuron-specific RNAi against <italic>mce-1</italic> in the <italic>ogt-1;acdh-1</italic> double mutant had no observable effect (<xref ref-type="fig" rid="fig4">Figure 4F</xref>, <xref ref-type="supplementary-material" rid="fig4sdata1">Figure 4—source data 1</xref>). The <italic>acdh-1</italic>-mediated shunt pathway is involved in the production of acetyl CoA from L-Cystathionine which is used for several processes including lipid synthesis and/or ATP production. Thus, we tested if lipid synthesis plays a role by neuron-specific RNAi against <italic>pod-2</italic> (acetyl-CoA carboxylase), an ortholog of human ACACA (acetyl-CoA carboxylase alpha), that is important for lipid synthesis from acetyl CoA, but found it had no effect on either WT or <italic>ogt-1</italic> regeneration (<xref ref-type="fig" rid="fig4">Figure 4G</xref>, <xref ref-type="supplementary-material" rid="fig4sdata1">Figure 4—source data 1</xref>). In contrast, the enhanced regeneration in <italic>ogt-1</italic> worms was clearly blocked by neuron-specific RNAi against <italic>atp-3</italic> RNAi that reduces cellular ATP production, (as described above earlier <xref ref-type="fig" rid="fig1">Figure 1C</xref> and <xref ref-type="fig" rid="fig4">Figure 4G</xref>, <xref ref-type="supplementary-material" rid="fig4sdata1">Figure 4—source data 1</xref>). Since perturbation in O-GlcNAc signaling is known to affect lipid metabolism (<xref ref-type="bibr" rid="bib42">Lockridge and Hanover, 2022</xref>) and lipid metabolism is a significant source of energy in neurons (<xref ref-type="bibr" rid="bib60">Tracey et al., 2018</xref>), we investigated if ATP generation <italic>via</italic> beta-oxidation of lipids plays a role. However, neuron-specific RNAi against, <italic>acs-2,</italic> acyl-CoA synthetase family member 2 (ortholog of human ACSF2), or <italic>cpt-2,</italic> carnitine palmitoyl transferase (ortholog of human CPT1A, carnitine palmitoyl transferase 1 A and CPT1C, carnitine palmitoyl transferase 1 C) did not affect enhanced regeneration in <italic>ogt-1</italic> animals (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1C</xref>, <xref ref-type="supplementary-material" rid="fig4s1sdata2">Figure 4—figure supplement 1—source data 2</xref>). While RNAi knockdown does suffer from gene specific variability, both <italic>acs-2</italic> and <italic>cpt-2</italic> are important for lipid beta-oxidation, suggesting that the process is not fundamental in <italic>ogt-1</italic> regeneration. Regardless, in combination with gene expression analysis, these results help to further define the pathway of <italic>ogt-1</italic> regeneration to specifically involve acetyl CoA production by cystathionine metabolism through the vitamin B12 independent shunt pathway.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>In order to initiate and sustain the energetically demanding growth state required for effective regeneration there must be sufficient modulation of the underlying molecular and metabolic processes within the damaged neuron (<xref ref-type="bibr" rid="bib24">He and Jin, 2016</xref>). Numerous studies have focused on the molecular and genetic mechanisms involved in axonal regeneration (<xref ref-type="bibr" rid="bib56">Sun et al., 2014</xref>; <xref ref-type="bibr" rid="bib9">Chisholm et al., 2016</xref>; <xref ref-type="bibr" rid="bib10">Chung et al., 2016</xref>). Yet the role of metabolic pathways is relatively less explored, despite its clear role in determining regenerative capacity (<xref ref-type="bibr" rid="bib58">Taub et al., 2018</xref>; <xref ref-type="bibr" rid="bib37">Li et al., 2020</xref>; <xref ref-type="bibr" rid="bib70">Yang et al., 2020</xref>). Previously, our group demonstrated that genetically altered O-GlcNAc levels can substantially enhance neuronal regeneration through modulation of the neuronal metabolic response (<xref ref-type="bibr" rid="bib58">Taub et al., 2018</xref>). Exploiting the genetic and optical accessibility of <italic>C. elegans</italic>, we demonstrated that a reduction of O-GlcNAc levels (<italic>via ogt-1</italic> deletion mutation), a proxy for the metabolic deficit, supports increased regenerative capacity (<xref ref-type="bibr" rid="bib58">Taub et al., 2018</xref>). In this study, we verified these effects in the <italic>ogt-1</italic>(deletion) mutation as before (<xref ref-type="fig" rid="fig1">Figure 1B</xref>) and found similar results in the catalytically dead mutant allele (OG1135) (<xref ref-type="fig" rid="fig1">Figure 1B</xref>), demonstrating that the lack of OGT-1 enzymatic activity is important as opposed to a possible non-catalytic function (<xref ref-type="bibr" rid="bib34">Konzman et al., 2022</xref>; <xref ref-type="bibr" rid="bib48">Pravata et al., 2019</xref>). Earlier, we found that disruption of key elements of the glycolytic pathway selectively eliminates the enhanced regeneration of the <italic>ogt-1</italic> mutant (<xref ref-type="bibr" rid="bib58">Taub et al., 2018</xref>). Glycolysis is a key energy source for neurons, particularly under energy-limiting conditions (<xref ref-type="bibr" rid="bib26">Jang et al., 2016</xref>) and in developing neurons that foster high axonal growth rates (<xref ref-type="bibr" rid="bib22">Han et al., 2016</xref>; <xref ref-type="bibr" rid="bib75">Zheng et al., 2016</xref>; <xref ref-type="bibr" rid="bib23">Han et al., 2020</xref>). We further verified this by neuron-specific RNAi knockdown of <italic>atp-3</italic>, which significantly reduces cellular ATP levels (<xref ref-type="bibr" rid="bib53">Soto et al., 2020</xref>) and blocks the enhance regeneration in <italic>ogt-1</italic> animals (<xref ref-type="fig" rid="fig1">Figure 1D</xref>). While our previous work established that the early steps of neuronal glycolysis are a key component of enhanced axonal regeneration following injury in <italic>ogt-1</italic> worms (<xref ref-type="bibr" rid="bib58">Taub et al., 2018</xref>), key questions remained as to the specific metabolic pathways that are amended and involved to support regeneration.</p><p>Our results here indicate that a complex metabolic pathway beyond that of canonical glycolysis is involved (<xref ref-type="fig" rid="fig5">Figure 5</xref>). In our earlier study, we demonstrated the importance of early glycolytic enzymes (<italic>pfk-1.1</italic> and <italic>pgk-3</italic>) in the <italic>ogt-1</italic> effect (<xref ref-type="bibr" rid="bib58">Taub et al., 2018</xref>). However, we found here that this does not extend to the complete glycolytic pathway as neuron-specific disruption of pyruvate kinase (<italic>pyk-1</italic>), which catalyzes the final step of glycolysis to produce pyruvate, had no effect on regeneration in <italic>ogt-1</italic> (<xref ref-type="fig" rid="fig1">Figure 1D</xref>). This is in accordance with the reported effects of O-GlcNAcylation on these enzymes. High O-GlcNAcylation decreases <italic>pfk-1.1</italic> function (<xref ref-type="bibr" rid="bib1">Bacigalupa et al., 2018</xref>). Despite the fact that high O-GlcNAcylation also destabilizes the pyruvate kinase, PKM1/2, complex (<xref ref-type="bibr" rid="bib64">Wang et al., 2017</xref>), reports show that inhibition of <italic>ogt-1</italic> results in low pyruvate kinase expression and cellular activity (<xref ref-type="bibr" rid="bib72">Yu et al., 2019a</xref>). The <italic>ogt-1</italic> mutation, which reduces O-GlcNAcylation, is therefore expected to increase <italic>pfk-1.1,</italic> and reduce <italic>pyk-1</italic>, activity, respectively, which agrees with their measured importance in <italic>ogt-1</italic> neuron regeneration.</p><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>The metabolic pathway essential for enhanced neuronal regeneration in O-GlcNAc transferase (<italic>ogt-1)</italic> animals.</title><p>A detailed schematic of the metabolic pathway essential for the enhanced regeneration in <italic>ogt-1</italic> animals with the tested genes, metabolite supplementations, and pharmacological treatments indicated. As highlighted in green, <italic>ogt-1</italic> mutations required metabolic pathways apart from glycolysis including one-carbon metabolism (OCM)<italic>,</italic> the SPP, the transsulfuration pathway (TSP), and the vitamin B12 independent shunt pathway to support enhanced regeneration. Dispensable metabolic branches are shown in red. Different genetic manipulations (RNAi and mutants) in respective pathways are mentioned at respective places along with methionine and cystathionine metabolites supplementation. Details are mentioned in the main manuscript text.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-86478-fig5-v1.tif"/></fig><p>As these results indicate that the increased regeneration in <italic>ogt-1</italic> mutants does not entail direct ATP production in the TCA cycle of canonical glycolysis, we further adopted an unbiased approach performing genome-wide gene expression analysis to identify additional pathways involved. Through GO and KEGG pathway classification analysis of RNA-seq data from wild-type and <italic>ogt-1</italic> mutant animals, we identified several metabolic pathways altered in both whole animals and FACs sorted neuron samples (<xref ref-type="fig" rid="fig2">Figure 2B–E</xref>, <xref ref-type="supplementary-material" rid="fig2sdata1">Figure 2—source data 1</xref>, and <xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2C–D</xref>, <xref ref-type="supplementary-material" rid="fig2sdata2">Figure 2—source data 2</xref>). In addition to numerous genes and cellular processes with known roles in regeneration such as amino acid, nucleotide metabolism, lipid synthesis, methylation, and glycolysis (<xref ref-type="bibr" rid="bib16">Ducker and Rabinowitz, 2017</xref>; <xref ref-type="bibr" rid="bib11">Clare et al., 2019</xref>), our analysis further identified metabolic processes including glutathione and s-adenosyl methionine (SAM) metabolism, energy metabolism, and ATP synthesis that were significantly enriched in the <italic>ogt-1</italic> background. This pathway enrichment analysis indicates the involvement of OCM and its associated pathways in enhanced regeneration in <italic>ogt-1</italic> animals (<xref ref-type="fig" rid="fig2">Figure 2B–F</xref> and <xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2A–B</xref>). These results were further confirmed <italic>via</italic> specific gene expression analysis using qRT-PCR (<xref ref-type="fig" rid="fig2">Figure 2G</xref> and <xref ref-type="fig" rid="fig4">Figure 4D</xref>) and indicate the importance of OCM and the TSP as key metabolic pathways altered by the <italic>ogt-1</italic> mutation (<xref ref-type="fig" rid="fig2">Figure 2D–F</xref>).</p><p>OCM is involved in a wide array of cellular processes including nucleotide biosynthesis (purines and thymidine), amino acid homeostasis (glycine, serine, and methionine), epigenetic maintenance (nucleic acid and histone methylation), and redox defense (<xref ref-type="bibr" rid="bib16">Ducker and Rabinowitz, 2017</xref>). Enhanced glycolysis drives OCM through the SSP (<xref ref-type="bibr" rid="bib41">Locasale, 2013</xref>; <xref ref-type="bibr" rid="bib73">Yu et al., 2019b</xref>) that is known to be involved in several neuronal conditions including, neuronal growth, neural tube defect, and Alzheimer’s disease (<xref ref-type="bibr" rid="bib12">Coppede, 2010</xref>; <xref ref-type="bibr" rid="bib3">Bonvento and Bolaños, 2021</xref>; <xref ref-type="bibr" rid="bib39">Lionaki et al., 2022</xref>). Through a combination of genetic manipulation, pharmacological treatment, and metabolic supplementation in our <italic>C. elegans</italic> neuronal regeneration assays, we have determined the specific metabolic pathway by which OCM contributes to the enhanced regeneration in the <italic>ogt-1</italic> mutant. The complete pathway is illustrated in green in <xref ref-type="fig" rid="fig5">Figure 5</xref>. We found that metabolic flux diverted from the early steps of glycolysis towards OCM through SSP is crucial, which is in agreement with earlier reports where enhanced glycolysis diverts metabolic flux towards OCM through SSP (<xref ref-type="bibr" rid="bib73">Yu et al., 2019b</xref>). This was most dramatically illustrated by the reduction in regeneration from pharmacological, or genetic, disruption of <italic>phgdh-1</italic> (<italic>C31C9.2,</italic> ortholog of human <italic>PHGDH</italic>)<italic>,</italic> a key element of the SSP. The role of the SSP was further confirm by serine supplementation in the <italic>akt-1</italic> and <italic>ogt-1</italic> double mutant (<italic>ogt-1;akt-1</italic>), which restored the enhanced <italic>ogt-1</italic> regeneration blocked by the <italic>akt-1</italic> mutation (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A</xref>). These results are in agreement with earlier metabolomic findings that enhanced glycolysis (<xref ref-type="bibr" rid="bib73">Yu et al., 2019b</xref>) and/or knock down of PMK1/2 (mammalian ortholog of <italic>pyk-1</italic>) diverts metabolic flux toward serine synthesis pathway to sustain cellular metabolic requirements (<xref ref-type="bibr" rid="bib72">Yu et al., 2019a</xref>). Here, we have focused our study on SSP, OCM, and TSP because the pathway analysis of our RNA-seq data suggested they were most affected in <italic>ogt-1</italic> animals. However, it is likely that additional metabolic pathways associated with glycolysis, such as the pentose phosphate pathway (PPP, elements of which are dynamically O-GlcNAcylated in response to hypoxic stress <xref ref-type="bibr" rid="bib49">Rao et al., 2015</xref>), are also affected by <italic>ogt-1</italic> mutation and <italic>pyk-1</italic> knock down. Further investigation of these additional pathways should prove beneficial in the future.</p><p>Although OCM is involved in both lipogenesis and DNA transmethylation (<xref ref-type="bibr" rid="bib30">Kersten, 2001</xref>; <xref ref-type="bibr" rid="bib73">Yu et al., 2019b</xref>) that could potentially play significant roles in increasing neuron regeneration (<xref ref-type="bibr" rid="bib25">Iskandar et al., 2010</xref>), we found that the regeneration effects of <italic>ogt-1</italic> were primarily dependent on L-cystathionine metabolism <italic>via</italic> the downstream TSP (<xref ref-type="fig" rid="fig4">Figure 4C</xref>). The TSP is influenced by OCM and its metabolites and has been reported to play an important role in neurodegenerative diseases and ATP production (<xref ref-type="bibr" rid="bib19">Giese et al., 2020</xref>; <xref ref-type="bibr" rid="bib35">Lam et al., 2021</xref>). We found that cystathionine supplementation rescued the prohibitory effects of blocking the SSP pathway in the <italic>ogt-1</italic> background (<xref ref-type="fig" rid="fig4">Figure 4C</xref>). Testing branches of the TSP, we found that only the vitamin B12 independent shunt pathway was required, <italic>via</italic> Acyl CoA dehydrogenase (<italic>acdh-1</italic>), for <italic>ogt-1-</italic>mediated enhanced regeneration. The shunt pathway generates Acetyl-CoA that will drive ATP production through the Kreb’s cycle ultimately bringing the metabolic consequences of <italic>ogt-1</italic> back to cellular energy production and utilization as we demonstrated in Taub et al., Though, we observed a significant decrease in ATP levels (<xref ref-type="fig" rid="fig1">Figure 1F</xref>, <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1C</xref>) and no difference in ATP utilization (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1D</xref>) in <italic>ogt-1</italic> animals, these observations were either in whole worms or in nonneuronal tissues rather than neuron-specific. Indeed, the down regulation of <italic>pyk-1</italic> from <italic>ogt-1</italic> inhibition has been associated with total reduced ATP levels previously (<xref ref-type="bibr" rid="bib13">Dey et al., 2019</xref>). Regardless, our work here has now deciphered a specific metabolic pathway through which the enhanced regenerative effect of <italic>ogt-1</italic> occurs.</p><p>While the <italic>ogt-1</italic> mutant rewires metabolic flux through a specific pathway to support and sustain enhance regeneration, we also discovered several additional conditions where restriction or diversion of metabolic flux in wild-type animals has similar beneficial effects. For instance, the HBS pathway nominally shunts off ~5% of glycolytic flux (<xref ref-type="bibr" rid="bib44">Marshall et al., 1991</xref>; <xref ref-type="bibr" rid="bib2">Bond and Hanover, 2015</xref>). We found that blocking the HBS pathway through RNAi against <italic>gfat-1</italic> and <italic>gfat-2</italic> (<xref ref-type="bibr" rid="bib71">Yi et al., 2012</xref>; <xref ref-type="bibr" rid="bib27">Jóźwiak and Forma, 2014</xref>; <xref ref-type="bibr" rid="bib32">Kim et al., 2018</xref>), appears to divert metabolic flux towards glycolysis and results in enhanced regeneration in WT animals similar to that of <italic>ogt-1</italic> (<xref ref-type="fig" rid="fig1">Figure 1C</xref>). Likewise, <italic>pyk-1</italic> knockdown increases regeneration in WT and is known to divert metabolic flux toward the SSP (<xref ref-type="bibr" rid="bib72">Yu et al., 2019a</xref>). Within OCM, we found that transmethylation pathways required for epigenetic modifications and phospholipid synthesis were not essential for the enhanced regeneration in <italic>ogt-1</italic> animals but that blocking histone methyl transferases in WT animals increased regeneration (<xref ref-type="fig" rid="fig3">Figure 3I</xref>). In addition, supplementation in wild type with the metabolite, L-methionine (product of <italic>metr-1</italic>), which increases OCM, phenocopied the enhance regeneration of the <italic>ogt-1</italic> mutant (<xref ref-type="fig" rid="fig3">Figure 3F</xref>) as did blocking neuronal glutathione synthesis within the TSP (<italic>gss-1</italic> RNAi) (<xref ref-type="fig" rid="fig4">Figure 4B</xref>). While in the above instances restriction or enhancement of specific metabolic steps could be augmenting the same pathway utilized in <italic>ogt-1</italic> regeneration, in other cases clearly alternative pathways are at work. For example, pharmacologically (NCT502 treatment) or genetically (<italic>phgdh-1</italic> knock down) blocking SSP which restricts the <italic>ogt-1</italic> regeneration pathway effectively increases regeneration in WT. This effect is possibly due to increased metabolic flux through glycolysis, as we observed increased activity of <italic>pyk-1</italic> after NCT502 treatment (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1C</xref>). Likewise, we had previously found that mutation of the O-GlcNAcase, <italic>oga-1</italic>, which increases O-GlcNAc levels, also increased neuron regeneration in <italic>C. elegans,</italic> but did so through an independent pathway of enhanced mitochondrial stress response (<xref ref-type="bibr" rid="bib58">Taub et al., 2018</xref>).</p><p>Thus, within the complex web of cellular metabolism and energy production there appears to be numerous pathways for metabolite utilization that are beneficial for neuron regeneration. Here, employing genetic tools, we have defined a specific array of metabolic pathways (glycolysis, SSP, OCM, and TSP) through which the <italic>ogt-1</italic> mutation diverts metabolic flux to increase neuronal regeneration. It is important to emphasize the accessibility of these metabolic effects to pharmacological treatment and/or metabolite supplements. For example, we previously demonstrated increased regeneration in wild-type animals with glucose supplementation (<xref ref-type="bibr" rid="bib58">Taub et al., 2018</xref>). Here, we find similar effects with L-methionine supplementation or treatment with the SSP blocking agent NCT502 in wild-type animals. Nutrient supplements and metabolic drug targets have been employed in neurotherapeutic treatments and prevention in numerous contexts including neuronal developmental defects (<xref ref-type="bibr" rid="bib20">Greene et al., 2017</xref>; <xref ref-type="bibr" rid="bib4">Businaro et al., 2021</xref>; <xref ref-type="bibr" rid="bib68">Wu et al., 2022</xref>) and age-associated neurodegenerative diseases (<xref ref-type="bibr" rid="bib54">Stempler et al., 2014</xref>; <xref ref-type="bibr" rid="bib4">Businaro et al., 2021</xref>). While our current study has specifically focused on the neuronal regeneration of the mechanosensory neurons in <italic>C. elegans</italic>, O-GlcNAc signaling has been widely implicated in regulating various neuronal cellular processes in higher organisms. This includes axon growth, synaptic plasticity, and neurite outgrowth (<xref ref-type="bibr" rid="bib59">Tian et al., 2023</xref>; <xref ref-type="bibr" rid="bib46">Mutalik and Gupton, 2021</xref>) and has been linked to the modulation of gene expression during neuronal repair in higher animals including mammals (<xref ref-type="bibr" rid="bib36">Lee et al., 2021</xref>; <xref ref-type="bibr" rid="bib55">Su and Schwarz, 2017</xref>). These studies suggest that functions of O-GlcNAc signaling are conserved throughout the nervous system and across species. Future work will be required to determine to what degree this holds true specifically in the context of neuronal regeneration. Regardless, our work here demonstrates the role of OCM, SSP, and TSP metabolic pathways in the increased regenerative capacity of a damaged neuron in <italic>ogt-1 C. elegans</italic> and highlights the potential power for such metabolic targets in the treatment of neuronal injury.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><sec id="s4-1"><title>Reagents and resources</title><p>Further information and requests for resources, data, and reagents should be directed to and will be fulfilled by the Lead Contact, Christopher V. Gabel (cvgabel@bu.edu).</p></sec><sec id="s4-2"><title>Experimental model and subject details</title><p>All <italic>C. elegans</italic> strains were cultured and maintained at 20 °C on nematode growth media (NGM) agar plates seeded with OP50 <italic>E. coli</italic>, unless otherwise noted. Strains were obtained from the <italic>Caenorhabditis</italic> Genetics Consortium (CGC at the University of Minnesota). To visualize the mechanosensory neurons, strains were crossed either into SK4005 (zdis5 [pmec4::GFP]) or <italic>ogt</italic>-1::zdis-5. Strains used are listed in detail in the appendix table at the end of the manuscript. All strains generated by crossing were confirmed by genotyping using primers recommended by the CGC.</p></sec><sec id="s4-3"><title>Laser axotomy</title><p>In vivo Laser Axotomy was performed with a Ti:Sapphire infrared laser system (Mantis PulseSwitch Laser, Coherent Inc), that generated a 1 mHz train of 100 fs pulses in the near infrared (800 nm), pulse energy of 15–30 nJ/pulse or with a Yb-doped diode-pumped solid-state laser (SpectraPhysics Spirit-1040–4 W) outputting 1040 nm 400 fs pulses at 1 kHz (<xref ref-type="bibr" rid="bib65">Wang et al., 2022</xref>). Axotomy was performed on a Nikon Ti-2000 inverted fluorescent microscope with a Nikon 40X 1.4 NA objective or with a Nikon Plan Apochromat Lambda 1.4 NA, 60 X oil-immersion objective. Neurons were imaged for axotomy and subsequent measurement of regeneration <italic>via</italic> standard wide-field fluorescence of gfp expressed in the targeted neuron. Day 1 adult <italic>C. elegans</italic> were mounted on 5–6% agarose pads and immobilized in a 3–5 μL slurry of polystyrene beads (Polysciences, Polybead Polystyrene, 0.05 μM microsphere, cat#08691–10) and NGM buffer (<xref ref-type="bibr" rid="bib31">Kim et al., 2013</xref>). Axotomy consisted of 3–5 short laser exposures (0.25 s each) resulting in vaporization at the focal point and severing of the targeted axon. The anterior lateral microtubule (ALM) neuron was injured with two targeted cuts. The first cut was made 20 μm from the cell soma and a second cut was made 40–50 μm from the cell soma, creating a 20–30 μm gap. Regeneration lengths were reimaged with a Nikon 40X 1.4 NA objective 24 hr after axotomy, or as otherwise indicated, by placing the animals on a 2% agarose pad with 5 mM sodium azide. Regeneration lengths were measured by tracing along the new neuron outgrowth both from the proximal ablation point as well as any new backward growth from the soma with ImageJ/FIJI. On an average for each condition, we have performed axotomy and measured regeneration for at least ~20 worms, exact numbers for each experiment are given in the associated supplementary data tables.</p></sec><sec id="s4-4"><title>Mechanosensory neuron-specific RNAi feeding</title><p>To evaluate the function of specific genes, RNAi gene knockdown was employed following protocols we used previously, Taub et al., These protocols were first confirmed by performing RNAi knockdown against GFP in mechanosensory neurons. Significant reduction in GFP fluorescence was observed equivalent to the results reported in Taub et al, confirming neuron specific gene knockdown. Both the Ahringer and Vidal bacterial RNAi libraries were employed (<xref ref-type="bibr" rid="bib29">Kamath and Ahringer, 2003</xref>; <xref ref-type="bibr" rid="bib50">Rual et al., 2004</xref>). Following standard protocols, bacteria colonies were streaked out on LB agar containing penicillin and grown at 37 °C overnight. The next day, single colonies were selected and grown in 10 mL of LB with Ampicillin overnight at 37 °C. From this subculture, 250 micro-liters (uL) were spread onto RNAi agar plates containing penicillin and 2 mM IPTG. Plates were dried and incubated at room temperature for at least 48 hr before using them for worm culturing. For mechanosensory neuron-specific RNAi gene knockdown, we employed the TU3568 (sid-1(pk3321) him-5(e1490) V; lin-15B(n744) X; uIs71 [(pCFJ90) pmyo-2::mCherry + pmec-18::sid-1]) background (<xref ref-type="bibr" rid="bib6">Calixto et al., 2010</xref>). This strain has RNAi sensitivity specifically in the mechanosensory neurons and is RNAi resistant in all other tissues. TU3568 was crossed into the <italic>ogt-1</italic> mutant background. Following protocols we established in <xref ref-type="bibr" rid="bib58">Taub et al., 2018</xref>, gravid adults were bleached, and embryos were allowed to hatch onto RNAi-bacteria plates. Once the F1 generation reached adulthood, 30–40 gravid adults were picked onto fresh RNAi-bacteria plates and allowed to lay eggs for 3–4 hr. The day 1 adults of the F2 generation was then used for Laser Axotomy and regeneration assays as described above. Animals were rescued on a fresh RNAi plate and cultured until imaging was performed.</p></sec><sec id="s4-5"><title>Drug treatments in <italic>C. elegans</italic></title><p>For all chemical reagent and metabolite treatments, the compound was dissolved in NGM agar before being poured into plates. Animals were cultured on treated plates for their lifespan before and after axotomy. Choline 30 mM (Sigma, Cat#: C7017-5G), (<xref ref-type="bibr" rid="bib14">Ding et al., 2015</xref>), L-Methionine 75 μM (Fisher Scientific, Cat#: AC166160025), 5 mM L-Serine (Sigma, cat# S-4500) (<xref ref-type="bibr" rid="bib40">Liu et al., 2019</xref>), L-Cystothionine 50 μM (Sigma, Cat#: C7017-5G, CAS:67-48-1), and L-Glutathione reduced 100 μM (Cat#: G4251-50G), were dissolved in molecular grade water (Fisher Scientific, Cat#: R91450001G, CAS: 7732-18-5) at required stock concentrations (<xref ref-type="bibr" rid="bib17">Ellwood et al., 2022</xref>). The phgdh (C31C9.2) inhibitor N-(4,6-dimethylpyridin-2-yl)–4-[5-(trifluoromethyl)yridine-2-yl]piperazine-1-carbothioamid (NCT502) (MedChemExpress, Cat#: HY-117240) was initially dissolved in DMSO and diluted in ddH2O to use at a concentration of 25 μM in NGM plates (<xref ref-type="bibr" rid="bib47">Pacold et al., 2016</xref>). Note: We have shown previously that DMSO does not affect regeneration (<xref ref-type="bibr" rid="bib58">Taub et al., 2018</xref>). All the drugs, chemicals, and kits used are listed in the appendix table at the end of the manuscript.</p></sec><sec id="s4-6"><title>qRT-PCR</title><p>To evaluate the expression levels of candidate genes in wild-type and <italic>ogt-1</italic> animals we performed qRT-PCR. Day 1 adult <italic>C. elegans</italic> were lysed in 0.5% SDS, 5% b-ME, 10 mM EDTA, 10 mM Tris-HCl pH 7.4, 0.5 mg/ml Proteinase K, then RNA was purified with Tri-Reagent (Sigma). DNAse I treatment (NEB M03035) of 2–3 ug RNA followed by cDNA conversion using High-Capacity cDNA Reverse Transcription Kit (Thermo Fisher Scientific cat#4368814). qRT-PCR was performed in biological triplicate with three technical triplicates for each condition using Real-Time PCR Quantstudio 12 K Flex qPCR System and Fast SYBR Green Master Mix (Thermo Fisher, 4385617). Relative transcript abundance was determined by using the DDCt method and normalized to <italic>act-1</italic> mRNA expression levels as a control. Primers are listed in the appendix table at the end of the manuscript.</p></sec><sec id="s4-7"><title>Neuronal cell isolation from adult animals using FACs</title><p>To isolate neuronal cells from Day 1 adult worms we utilized the protocol developed and described earlier (<xref ref-type="bibr" rid="bib74">Zhang et al., 2011</xref>; <xref ref-type="bibr" rid="bib28">Kaletsky et al., 2016</xref>). In brief WT (<italic>unc-119:</italic>:GFP) and <italic>ogt-1</italic> (<italic>ogt-1::unc-119</italic>::GFP) worms expressing GFP in all neurons were generated by crossing WT or OGT-1 worms with otIs45 [<italic>unc-119</italic>::GFP]. Synchronized day 1 adult worms were washed (3 X) with s-basal buffer to remove excess bacteria. The packed worm volume (250–350 μl) was washed twice with 500 μl lysis buffer (200 mM DTT, 0.25% SDS, 20 mM HEPES pH 8.0, 3% sucrose) and resuspended in 1000 μl lysis buffer. Worms were incubated in lysis buffer with intermittent gentle tapping for 10 min at room temperature. The pellet was washed 6 X with s-basal and resuspended in 20 mg/ml pronase solution from Streptomyces griseus (Sigma- Aldrich, SKU# 10165921001). Worms were incubated at room temperature (15–20 min) with periodic mechanical disruption by pipetting at every 2 min intervals. When most worm bodies were dissociated, leaving only small debris and eggs (as observed under a dissecting microscope), dissolved whole worm tissues were filtered to remove eggs and single cells were pelleted down at 4 K RPM for 20 min at 4 °C. The pellets were resuspended in ice-cold PBS buffer containing 2% fetal bovine serum (Gibco). The resulting dissociated cell suspension was subjected to Fluorescence-activated cell sorting (FACs) to isolate GFP labeled neurons (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A</xref>).</p></sec><sec id="s4-8"><title>Expression profiling by RNA-seq</title><p>Gene expression patterns in WT and <italic>ogt-1</italic> mutants were measured by RNA-seq analysis from RNA extracted from both, day 1 adult, whole animal and FACs sorted neuronal cells. RNA from FACS-sorted neurons were extracted using the Direct-zol RNA Miniprep Plus Kit (Zymo Research, R2070). RNA from whole animals was extracted manually by lysing day 1 adult <italic>C. elegans</italic> in 0.5% SDS, 5% b-ME, 10 mM EDTA, 10 mM Tris-HCl pH 7.4, 0.5 mg/ml Proteinase K, then RNA was purified with Tri-Reagent (Sigma cat# T9424-25ML). Isolated RNA was purified by RNAeasy columns (QIAGEN, Cat#74034), and the quality of RNA was evaluated with the 2100 bioanalyzer (Agilent) before library generation for the RNA-seq experiments. RNA-seq experiments were not randomized, nor results blinded, as all analysis is fully automated and unbiased. For whole-worm and neuron-specific RNA sequencing of adult animals N=2 biological replicates were used. No statistical methods were used to predetermine sample size (<xref ref-type="bibr" rid="bib28">Kaletsky et al., 2016</xref>).</p><p>For whole-body RNA-seq analysis we acquired DNBseq RNA sequencing services from BGI Global (<ext-link ext-link-type="uri" xlink:href="https://gtech.bgi.com/bgi/home">https://gtech.bgi.com/bgi/home</ext-link>). Total RNA-seq and data analysis were performed by using BGI Global inhouse developed sequencing methods and data analysis. In brief, transcriptome libraries were generated using the library conversion kit before sequencing was performed on the DNBseq platform. For each library, 10 ng library was used to incorporate a 5′ phosphorylation, on the forward strand only, using polymerase chain reaction (PCR). Purified PCR product with 5′ phosphorylation was then denatured and mixed with an oligonucleotide ‘splint’ that is homologous to the P5 and P7 adapter regions of the library to generate a ssDNA circle. A DNA ligation step was then performed to create a complete ssDNA circle of the forward strand, followed by an exonuclease digestion step to remove single-stranded non-circularized DNA molecules. Circular ssDNA molecules were then further subjected to Rolling Circle Amplification (RCA) to generate DNA Nanoballs (DNB) containing 300–500 copies of the libraries. Each DNB library was then drawn through a flow cell ready for sequencing using the DNBseq platform to generate 30 M clean reads per sample. FASTQ files were generated locally at sequencing performed by BGI. After data cleaning, processing includes removing adaptors, contamination, and low-quality reads. Bowtie2 was used to map the clean reads to the reference gene sequence (transcriptome), and then RSEM was used to calculate the gene expression level of each sample. The DEseq2 method was used to detect DEGs.</p><p>For neuron-specific RNA-seq analysis we employed the Illumina NextSeq 2000 RNA sequencing services from ‘The Boston University Microarray &amp; Sequencing Resource’ (<ext-link ext-link-type="uri" xlink:href="https://www.bumc.bu.edu/microarray/">https://www.bumc.bu.edu/microarray/</ext-link>). RNA isolated from FACs-sorted neuronal cells were subjected to quality control assessment using a bioanalyzer (Aligent). mRNA enrichment, library preparation and quality assessments were performed according to manufacturer protocols (Illumina). Sequencing was performed on the Illumina NextSeq 2000 System using the NextSeq 2000, P2 Reagent Kit (100 cycles) with sequencing read length 50 × 50 paired-end. Sequencing data were assessed for the quality of each sample using <bold>FastQC</bold> (<ext-link ext-link-type="uri" xlink:href="https://www.bioinformatics.babraham.ac.uk/projects/fastqc/">https://www.bioinformatics.babraham.ac.uk/projects/fastqc/</ext-link>), and <bold>RSeQC</bold> (<ext-link ext-link-type="uri" xlink:href="https://rseqc.sourceforge.net/">https://rseqc.sourceforge.net/</ext-link>). Each sample was aligned to the genome using <bold>STAR</bold> (<ext-link ext-link-type="uri" xlink:href="https://github.com/alexdobin/STAR">https://github.com/alexdobin/STAR</ext-link>; <xref ref-type="bibr" rid="bib15">Dobin, 2023</xref>), and <bold>SAMtools</bold> (<ext-link ext-link-type="uri" xlink:href="https://samtools.sourceforge.net/">https://samtools.sourceforge.net/</ext-link>) was used to count proper pairs of reads aligning to mitochondrial or ribosomal RNA. We confirmed <italic>ogt-1</italic> mutation by PCR genotyping (note: sequence alignment to the <italic>C. elegans</italic> genome using <bold>STAR</bold> was unable to confirm it). The subread package: high-performance read alignment, quantification, and mutation discovery <bold>featureCounts</bold> (<ext-link ext-link-type="uri" xlink:href="https://subread.sourceforge.net/">https://subread.sourceforge.net/</ext-link>) was used for alignment of proper read pairs unique to non-mitochondrial Ensemble Genes. As a control, all reads were also aligned to the GFP sequence, which indicated that all samples were GFP-positive as expected. To identify genes whose expression changes significantly between genotypes, a one-way analysis of variance (ANOVA) was performed using a likelihood ratio test to obtain a p-value for each gene. Benjamini-Hochberg false discovery rate (FDR) correction was applied to obtain FDR-corrected p-values (q-values), which represent the probability that a given result is a false positive based on the overall distribution of p-values. The FDR q-value was also recomputed after removing genes that did not pass the ‘independent filtering’ step in the DESeq2 package. Wald tests were then performed for each gene between experimental groups to obtain a test statistic and p-value for each gene. FDR correction was then applied, across all genes for which a p-value could be computed for all comparisons and across only those genes that passed expression filtering.</p></sec><sec id="s4-9"><title>RNA-seq bioinformatic analysis</title><p>The following unbiased enrichment analysis was used to understand whether the differentially expressed gene list identified in the RNA-seq data was significantly enriched in a pathway, molecular function, or particular biological process. <bold>GO</bold> was employed to determine the molecular function, cellular component, and biological process of the differentially expressed genes. All differentially expressed genes where mapped to terms in the Gene Ontology database (<ext-link ext-link-type="uri" xlink:href="http://www.geneontology.org/">http://www.geneontology.org/</ext-link>), the number of genes in each term calculated, and a hypergeometric test applied to identify GO terms that are significantly enriched in candidate genes compared to the background of all genes in the species. In addition, we also utilized the online ShinyGO v0.741: Gene Ontology Enrichment Analysis (<ext-link ext-link-type="uri" xlink:href="http://bioinformatics.sdstate.edu/go74/">http://bioinformatics.sdstate.edu/go74/</ext-link>) to analyze neuronally enriched genes. <bold>KEGG Pathway-based analysis</bold> (q-value ≤0.05) was employed to determine the most important biochemical metabolic and signal transduction pathways significantly enriched in the differentially expressed genes. The differentially expressed gene list was further analyzed for functional annotation of enriched pathways using The <bold>Database for Annotation, Visualization, and Integrated Discovery (DAVID</bold>). These tools are powered by the comprehensive DAVID Knowledgebase built upon the DAVID Gene concept which pulls together multiple sources of functional annotations. Using the recommended protocol for analysis in the wizard tool of DAVID (<ext-link ext-link-type="uri" xlink:href="https://david.ncifcrf.gov/tools.jsp">https://david.ncifcrf.gov/tools.jsp</ext-link>) we analyzed the pathways and metabolites most affected in neurons of <italic>ogt-1</italic> mutants.</p></sec><sec id="s4-10"><title>ATP quantification via the FRET-based ATP sensor</title><p>We obtained the worm strain (MS2495) expressing the fluorescence resonance energy transfer (FRET) based ATP sensor (novel<bold>C</bold>lover-<bold>A</bold>TP-<bold>mA</bold>pple fusion protein; <bold>CAmA</bold>) under the <italic>pept-1</italic> promoter expressed in the intestinal cells from Dr. Morris F Moduro lab (<xref ref-type="bibr" rid="bib53">Soto et al., 2020</xref>). Clover is a green fluorescent protein that is excited by blue light (480 nm-510 nm laser) and emits green light (511 nm-530 nm). mApple is a red fluorescent protein that is excited by green light (522 nm-577 nm) and emits red light (580 nm-675 nm). The <italic>ogt-1</italic> mutant was crossed with the ATP sensor strain (MS2495). The anterior gut of day 1 adult worms (control and <italic>ogt-1</italic> mutant) was imaged to measure FRET fluorescence using a 63 x objective on a confocal Zeiss LSM 880 microscope. Following established FRET imaging protocols, a mApple image was acquired first <italic>via</italic> direct excitation (561 nm laser) and emission (594 nm) to assess where the sensor protein was present and establish a baseline measurement. A second image was then obtained using a FRET filter set, i.e., excitation of Clover (488 nm laser), producing green emission (522 nm-577 nm) that excites mApple which is detected as red emission (516 nm) (FRETred). ImageJ was used to quantify the relative FRET pixel intensity (FRETred/baseline) within the region of interest.</p></sec><sec id="s4-11"><title>ATP and PPi quantification and <italic>pyk-1</italic> activity assay</title><p>Synchronized day 1 adult worms were collected in S-basal buffer and were washed 3 x with s-basal and 1 x in ATP assay buffer (Abcam, Ab83355), followed by sonication on ice in ATP assay buffer using a model 110 V/T Ultrasonic Homogenizer for two cycles of 15 min. Sonicated samples were then centrifuged at 13,000 RPM for 15 min at 4 °C. The supernatant was collected and moved to a fresh microcentrifuge tube and ATP quantitation was performed with the ATP Assay Kit (Colorimetric/Fluorometric) (Abcam, Ab83355) using a Tecan Infinite M1000 Pro Multi Microplate Reader. ATP was normalized to protein content measured with the BCA Protein Quantification Kit (Abcam, Ab102536). Triplicate technical replicates were performed for each sample; at least three biological samples were assayed for each condition reported. For <italic>pyk-1</italic> activity and pyrophosphate PPi quantification assays, animals were cultured as in ATP quantification assays and animals were sonicated on ice in respective assay buffers (<italic>pky-1</italic> or PPi assay buffer) and activity was recorded using a Tecan Infinite M1000 Pro Multi Microplate Reader. To normalize samples, the BCA Protein Quantification Kit (Abcam, Ab102536) was used.</p></sec><sec id="s4-12"><title>Quantification and statistical analysis</title><p>Statistical analysis and graph generation was performed with Prism (GraphPad). All data were compared with either WT, <italic>ogt-1</italic> mutant, or RNAi control regeneration data. Data are shown as the mean with error bars representing the standard error of the mean. One-way ANOVA analysis with Dunnett’s and <italic>post hoc</italic> Bonferroni’s correction was employed for multiple comparisons. When only two groups of data were compared an unpaired t-test was employed. In all cases, *p&lt;0.05 **p&lt;0.01, ***p&lt;0.001.</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Data curation, Formal analysis, Investigation, Writing – original draft, Writing – review and editing, Conceived and designed experiments. Performed all the experiments and aided in the analysis of data</p></fn><fn fn-type="con" id="con2"><p>Data curation, Investigation, Aided in confocal imaging and analysis</p></fn><fn fn-type="con" id="con3"><p>Investigation, Aided in laser ablation experiments</p></fn><fn fn-type="con" id="con4"><p>Funding acquisition, Investigation, Project administration, Provided laser ablation equipment and guidance</p></fn><fn fn-type="con" id="con5"><p>Conceptualization, Funding acquisition, Investigation, Writing – original draft, Project administration, Writing – review and editing, Conceived and designed experiments. Aided in all experiments and analysis of data</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="mdar"><label>MDAR checklist</label><media xlink:href="elife-86478-mdarchecklist1-v1.pdf" mimetype="application" mime-subtype="pdf"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>RNAseq data have been deposited at NCBI under accesses codes PRJNA938796 and PRJNA938805.</p><p>The following datasets were generated:</p><p><element-citation publication-type="data" specific-use="isSupplementedBy" id="dataset1"><person-group person-group-type="author"><name><surname>Yadav</surname><given-names>DK</given-names></name></person-group><year iso-8601-date="2023">2023</year><data-title><italic>Caenorhabditis elegans</italic> Raw sequence reads</data-title><source>NCBI BioProject</source><pub-id pub-id-type="accession" xlink:href="http://www.ncbi.nlm.nih.gov/bioproject/?term=PRJNA938796">PRJNA938796</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="isSupplementedBy" id="dataset2"><person-group person-group-type="author"><name><surname>Yadav</surname><given-names>DK</given-names></name></person-group><year iso-8601-date="2023">2023</year><data-title><italic>Caenorhabditis elegans</italic> Neuronal Cells RNA sequence data</data-title><source>NCBI BioProject</source><pub-id pub-id-type="accession" xlink:href="http://www.ncbi.nlm.nih.gov/bioproject/?term=PRJNA938805">PRJNA938805</pub-id></element-citation></p></sec><ack id="ack"><title>Acknowledgements</title><p>We would like to thank Dr. Amy Walker, UMASS Worcester, MA, USA, Dr. Morris Maduro, UC Riverside, and The <italic>C. elegans</italic> Genetics Center provided many of the strains and Boston University Core Dr. Tilton, Brian Richard (FACs); Dr. Yuriy Alekseyev (RNA sequencing and data analysis), Dr. Trinkaus-Randall (confocal Zeiss LSM 880 microscopy), and Dr. Lyn and Au, Matthew Bo (qRT-PCR) facilities for maintaining and making available different instruments for use. Dr. Walker provided <italic>sams-1</italic> worm, Dr. Maduro provided ATP expressing strain. Dr. Danial Taub provided feedback and suggestions on the manuscript. Funding was provided by the Massachusetts Spinal Cord Injury Cure Research Program, INTF3110HH2191525007, from the Massachusetts Department of Public Health to CVG and NIH R56NS128413 to SHC.</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bacigalupa</surname><given-names>ZA</given-names></name><name><surname>Bhadiadra</surname><given-names>CH</given-names></name><name><surname>Reginato</surname><given-names>MJ</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>O-GlcNAcylation: key regulator of glycolytic pathways</article-title><source>Journal of Bioenergetics and Biomembranes</source><volume>50</volume><fpage>189</fpage><lpage>198</lpage><pub-id pub-id-type="doi">10.1007/s10863-018-9742-3</pub-id><pub-id pub-id-type="pmid">29344764</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bond</surname><given-names>MR</given-names></name><name><surname>Hanover</surname><given-names>JA</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>A little sugar goes A long way: The cell biology of O-GlcNAc</article-title><source>Journal of Cell Biology</source><volume>208</volume><fpage>869</fpage><lpage>880</lpage><pub-id pub-id-type="doi">10.1083/jcb.201501101</pub-id><pub-id pub-id-type="pmid">25825515</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bonvento</surname><given-names>G</given-names></name><name><surname>Bolaños</surname><given-names>JP</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Astrocyte-neuron metabolic cooperation shapes brain activity</article-title><source>Cell Metabolism</source><volume>33</volume><fpage>1546</fpage><lpage>1564</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2021.07.006</pub-id><pub-id pub-id-type="pmid">34348099</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Businaro</surname><given-names>R</given-names></name><name><surname>Vauzour</surname><given-names>D</given-names></name><name><surname>Sarris</surname><given-names>J</given-names></name><name><surname>Münch</surname><given-names>G</given-names></name><name><surname>Gyengesi</surname><given-names>E</given-names></name><name><surname>Brogelli</surname><given-names>L</given-names></name><name><surname>Zuzarte</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Therapeutic opportunities for food supplements in neurodegenerative disease and depression</article-title><source>Frontiers in Nutrition</source><volume>8</volume><elocation-id>669846</elocation-id><pub-id pub-id-type="doi">10.3389/fnut.2021.669846</pub-id><pub-id pub-id-type="pmid">34055858</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Byrne</surname><given-names>AB</given-names></name><name><surname>Walradt</surname><given-names>T</given-names></name><name><surname>Gardner</surname><given-names>KE</given-names></name><name><surname>Hubbert</surname><given-names>A</given-names></name><name><surname>Reinke</surname><given-names>V</given-names></name><name><surname>Hammarlund</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Insulin/IGF1 Signaling Inhibits Age-Dependent Axon Regeneration</article-title><source>Neuron</source><volume>81</volume><fpage>561</fpage><lpage>573</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2013.11.019</pub-id><pub-id pub-id-type="pmid">24440228</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Calixto</surname><given-names>A</given-names></name><name><surname>Chelur</surname><given-names>D</given-names></name><name><surname>Topalidou</surname><given-names>I</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Chalfie</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Enhanced neuronal RNAi in <italic>C. elegans</italic> using SID-1</article-title><source>Nature Methods</source><volume>7</volume><fpage>554</fpage><lpage>559</lpage><pub-id pub-id-type="doi">10.1038/nmeth.1463</pub-id><pub-id pub-id-type="pmid">20512143</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cartoni</surname><given-names>R</given-names></name><name><surname>Norsworthy</surname><given-names>MW</given-names></name><name><surname>Bei</surname><given-names>F</given-names></name><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Gabel</surname><given-names>CV</given-names></name><name><surname>Schwarz</surname><given-names>TL</given-names></name><name><surname>He</surname><given-names>Z</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The mammalian-specific protein Armcx1 Regulates mitochondrial transport during axon regeneration</article-title><source>Neuron</source><volume>92</volume><fpage>1294</fpage><lpage>1307</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2016.10.060</pub-id><pub-id pub-id-type="pmid">28009275</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Calandrelli</surname><given-names>R</given-names></name><name><surname>Girardini</surname><given-names>J</given-names></name><name><surname>Yan</surname><given-names>Z</given-names></name><name><surname>Tan</surname><given-names>Z</given-names></name><name><surname>Xu</surname><given-names>X</given-names></name><name><surname>Hiniker</surname><given-names>A</given-names></name><name><surname>Zhong</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>PHGDH expression increases with progression of Alzheimer’s disease pathology and symptoms</article-title><source>Cell Metabolism</source><volume>34</volume><fpage>651</fpage><lpage>653</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2022.02.008</pub-id><pub-id pub-id-type="pmid">35508105</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chisholm</surname><given-names>AD</given-names></name><name><surname>Hutter</surname><given-names>H</given-names></name><name><surname>Jin</surname><given-names>Y</given-names></name><name><surname>Wadsworth</surname><given-names>WG</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The genetics of axon guidance and axon regeneration in <italic>Caenorhabditis elegans</italic></article-title><source>Genetics</source><volume>204</volume><fpage>849</fpage><lpage>882</lpage><pub-id pub-id-type="doi">10.1534/genetics.115.186262</pub-id><pub-id pub-id-type="pmid">28114100</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chung</surname><given-names>SH</given-names></name><name><surname>Awal</surname><given-names>MR</given-names></name><name><surname>Shay</surname><given-names>J</given-names></name><name><surname>McLoed</surname><given-names>MM</given-names></name><name><surname>Mazur</surname><given-names>E</given-names></name><name><surname>Gabel</surname><given-names>CV</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Novel DLK-independent neuronal regeneration in <italic>Caenorhabditis elegans</italic> shares links with activity-dependent ectopic outgrowth</article-title><source>PNAS</source><volume>113</volume><fpage>E2852</fpage><lpage>E2860</lpage><pub-id pub-id-type="doi">10.1073/pnas.1600564113</pub-id><pub-id pub-id-type="pmid">27078101</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clare</surname><given-names>CE</given-names></name><name><surname>Brassington</surname><given-names>AH</given-names></name><name><surname>Kwong</surname><given-names>WY</given-names></name><name><surname>Sinclair</surname><given-names>KD</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>One-carbon metabolism: Linking nutritional biochemistry to epigenetic programming of long-term development</article-title><source>Annual Review of Animal Biosciences</source><volume>7</volume><fpage>263</fpage><lpage>287</lpage><pub-id pub-id-type="doi">10.1146/annurev-animal-020518-115206</pub-id><pub-id pub-id-type="pmid">30412672</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coppede</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>One-carbon metabolism and Alzheimer’s disease: focus on epigenetics</article-title><source>Current Genomics</source><volume>11</volume><fpage>246</fpage><lpage>260</lpage><pub-id pub-id-type="doi">10.2174/138920210791233090</pub-id><pub-id pub-id-type="pmid">21119889</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dey</surname><given-names>P</given-names></name><name><surname>Son</surname><given-names>JY</given-names></name><name><surname>Kundu</surname><given-names>A</given-names></name><name><surname>Kim</surname><given-names>KS</given-names></name><name><surname>Lee</surname><given-names>Y</given-names></name><name><surname>Yoon</surname><given-names>K</given-names></name><name><surname>Yoon</surname><given-names>S</given-names></name><name><surname>Lee</surname><given-names>BM</given-names></name><name><surname>Nam</surname><given-names>KT</given-names></name><name><surname>Kim</surname><given-names>HS</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Knockdown of pyruvate kinase M2 inhibits cell proliferation, metabolism, and migration in renal cell carcinoma</article-title><source>International Journal of Molecular Sciences</source><volume>20</volume><elocation-id>5622</elocation-id><pub-id pub-id-type="doi">10.3390/ijms20225622</pub-id><pub-id pub-id-type="pmid">31717694</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ding</surname><given-names>W</given-names></name><name><surname>Smulan</surname><given-names>LJ</given-names></name><name><surname>Hou</surname><given-names>NS</given-names></name><name><surname>Taubert</surname><given-names>S</given-names></name><name><surname>Watts</surname><given-names>JL</given-names></name><name><surname>Walker</surname><given-names>AK</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>s-Adenosylmethionine levels govern innate immunity through distinct methylation-dependent pathways</article-title><source>Cell Metabolism</source><volume>22</volume><fpage>633</fpage><lpage>645</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2015.07.013</pub-id><pub-id pub-id-type="pmid">26321661</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Dobin</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2023">2023</year><data-title>Star</data-title><version designator="79affaa">79affaa</version><source>GitHub</source><ext-link ext-link-type="uri" xlink:href="https://github.com/alexdobin/STAR">https://github.com/alexdobin/STAR</ext-link></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ducker</surname><given-names>GS</given-names></name><name><surname>Rabinowitz</surname><given-names>JD</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>One-carbon metabolism in health and disease</article-title><source>Cell Metabolism</source><volume>25</volume><fpage>27</fpage><lpage>42</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2016.08.009</pub-id><pub-id pub-id-type="pmid">27641100</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ellwood</surname><given-names>RA</given-names></name><name><surname>Slade</surname><given-names>L</given-names></name><name><surname>Lewis</surname><given-names>J</given-names></name><name><surname>Torregrossa</surname><given-names>R</given-names></name><name><surname>Sudevan</surname><given-names>S</given-names></name><name><surname>Piasecki</surname><given-names>M</given-names></name><name><surname>Whiteman</surname><given-names>M</given-names></name><name><surname>Etheridge</surname><given-names>T</given-names></name><name><surname>Szewczyk</surname><given-names>NJ</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Sulfur amino acid supplementation displays therapeutic potential in a <italic>C. elegans</italic> model of Duchenne muscular dystrophy</article-title><source>Communications Biology</source><volume>5</volume><elocation-id>1255</elocation-id><pub-id pub-id-type="doi">10.1038/s42003-022-04212-z</pub-id><pub-id pub-id-type="pmid">36385509</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Geeraerts</surname><given-names>SL</given-names></name><name><surname>Heylen</surname><given-names>E</given-names></name><name><surname>De Keersmaecker</surname><given-names>K</given-names></name><name><surname>Kampen</surname><given-names>KR</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>The ins and outs of serine and glycine metabolism in cancer</article-title><source>Nature Metabolism</source><volume>3</volume><fpage>131</fpage><lpage>141</lpage><pub-id pub-id-type="doi">10.1038/s42255-020-00329-9</pub-id><pub-id pub-id-type="pmid">33510397</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giese</surname><given-names>GE</given-names></name><name><surname>Walker</surname><given-names>MD</given-names></name><name><surname>Ponomarova</surname><given-names>O</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Minevich</surname><given-names>G</given-names></name><name><surname>Walhout</surname><given-names>AJ</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title><italic>Caenorhabditis elegans</italic> methionine/S-adenosylmethionine cycle activity is sensed and adjusted by a nuclear hormone receptor</article-title><source>eLife</source><volume>9</volume><elocation-id>e60259</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.60259</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Greene</surname><given-names>NDE</given-names></name><name><surname>Leung</surname><given-names>KY</given-names></name><name><surname>Copp</surname><given-names>AJ</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Inositol, neural tube closure and the prevention of neural tube defects</article-title><source>Birth Defects Research</source><volume>109</volume><fpage>68</fpage><lpage>80</lpage><pub-id pub-id-type="doi">10.1002/bdra.23533</pub-id><pub-id pub-id-type="pmid">27324558</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hammarlund</surname><given-names>M</given-names></name><name><surname>Hobert</surname><given-names>O</given-names></name><name><surname>Miller</surname><given-names>DM</given-names></name><name><surname>Sestan</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>The CeNGEN Project: The complete gene expression map of an entire nervous system</article-title><source>Neuron</source><volume>99</volume><fpage>430</fpage><lpage>433</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2018.07.042</pub-id><pub-id pub-id-type="pmid">30092212</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Han</surname><given-names>SM</given-names></name><name><surname>Baig</surname><given-names>HS</given-names></name><name><surname>Hammarlund</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Mitochondria localize to injured axons to support regeneration</article-title><source>Neuron</source><volume>92</volume><fpage>1308</fpage><lpage>1323</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2016.11.025</pub-id><pub-id pub-id-type="pmid">28009276</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Han</surname><given-names>Q</given-names></name><name><surname>Xie</surname><given-names>Y</given-names></name><name><surname>Ordaz</surname><given-names>JD</given-names></name><name><surname>Huh</surname><given-names>AJ</given-names></name><name><surname>Huang</surname><given-names>N</given-names></name><name><surname>Wu</surname><given-names>W</given-names></name><name><surname>Liu</surname><given-names>N</given-names></name><name><surname>Chamberlain</surname><given-names>KA</given-names></name><name><surname>Sheng</surname><given-names>ZH</given-names></name><name><surname>Xu</surname><given-names>XM</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Restoring cellular energetics promotes axonal regeneration and functional recovery after spinal cord injury</article-title><source>Cell Metabolism</source><volume>31</volume><fpage>623</fpage><lpage>641</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2020.02.002</pub-id><pub-id pub-id-type="pmid">32130884</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>Z</given-names></name><name><surname>Jin</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Intrinsic control of axon regeneration</article-title><source>Neuron</source><volume>90</volume><fpage>437</fpage><lpage>451</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2016.04.022</pub-id><pub-id pub-id-type="pmid">27151637</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iskandar</surname><given-names>BJ</given-names></name><name><surname>Rizk</surname><given-names>E</given-names></name><name><surname>Meier</surname><given-names>B</given-names></name><name><surname>Hariharan</surname><given-names>N</given-names></name><name><surname>Bottiglieri</surname><given-names>T</given-names></name><name><surname>Finnell</surname><given-names>RH</given-names></name><name><surname>Jarrard</surname><given-names>DF</given-names></name><name><surname>Banerjee</surname><given-names>RV</given-names></name><name><surname>Skene</surname><given-names>JHP</given-names></name><name><surname>Nelson</surname><given-names>A</given-names></name><name><surname>Patel</surname><given-names>N</given-names></name><name><surname>Gherasim</surname><given-names>C</given-names></name><name><surname>Simon</surname><given-names>K</given-names></name><name><surname>Cook</surname><given-names>TD</given-names></name><name><surname>Hogan</surname><given-names>KJ</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Folate regulation of axonal regeneration in the rodent central nervous system through DNA methylation</article-title><source>Journal of Clinical Investigation</source><volume>120</volume><fpage>1603</fpage><lpage>1616</lpage><pub-id pub-id-type="doi">10.1172/JCI40000</pub-id><pub-id pub-id-type="pmid">20424322</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jang</surname><given-names>S</given-names></name><name><surname>Nelson</surname><given-names>JC</given-names></name><name><surname>Bend</surname><given-names>EG</given-names></name><name><surname>Rodríguez-Laureano</surname><given-names>L</given-names></name><name><surname>Tueros</surname><given-names>FG</given-names></name><name><surname>Cartagenova</surname><given-names>L</given-names></name><name><surname>Underwood</surname><given-names>K</given-names></name><name><surname>Jorgensen</surname><given-names>EM</given-names></name><name><surname>Colón-Ramos</surname><given-names>DA</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Glycolytic enzymes localize to synapses under energy stress to support synaptic function</article-title><source>Neuron</source><volume>90</volume><fpage>278</fpage><lpage>291</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2016.03.011</pub-id><pub-id pub-id-type="pmid">27068791</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jóźwiak</surname><given-names>P</given-names></name><name><surname>Forma</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>O-GlcNAcylation and metabolic reprograming in cancer</article-title><source>Frontiers in Endocrinology</source><volume>5</volume><elocation-id>145</elocation-id><pub-id pub-id-type="doi">10.3389/fendo.2014.00145</pub-id><pub-id pub-id-type="pmid">25250015</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaletsky</surname><given-names>R</given-names></name><name><surname>Lakhina</surname><given-names>V</given-names></name><name><surname>Arey</surname><given-names>R</given-names></name><name><surname>Williams</surname><given-names>A</given-names></name><name><surname>Landis</surname><given-names>J</given-names></name><name><surname>Ashraf</surname><given-names>J</given-names></name><name><surname>Murphy</surname><given-names>CT</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The <italic>C. elegans</italic> adult neuronal IIS/FOXO transcriptome reveals adult phenotype regulators</article-title><source>Nature</source><volume>529</volume><fpage>92</fpage><lpage>96</lpage><pub-id pub-id-type="doi">10.1038/nature16483</pub-id><pub-id pub-id-type="pmid">26675724</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kamath</surname><given-names>RS</given-names></name><name><surname>Ahringer</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Genome-wide RNAi screening in <italic>Caenorhabditis elegans</italic></article-title><source>Methods</source><volume>30</volume><fpage>313</fpage><lpage>321</lpage><pub-id pub-id-type="doi">10.1016/S1046-2023(03)00050-1</pub-id><pub-id pub-id-type="pmid">12828945</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kersten</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Mechanisms of nutritional and hormonal regulation of lipogenesis</article-title><source>EMBO Reports</source><volume>2</volume><fpage>282</fpage><lpage>286</lpage><pub-id pub-id-type="doi">10.1093/embo-reports/kve071</pub-id><pub-id pub-id-type="pmid">11306547</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>E</given-names></name><name><surname>Sun</surname><given-names>L</given-names></name><name><surname>Gabel</surname><given-names>CV</given-names></name><name><surname>Fang-Yen</surname><given-names>C</given-names></name><name><surname>Samuel</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Long-term imaging of <italic>Caenorhabditis elegans</italic> Using nanoparticle-mediated immobilization</article-title><source>PLOS ONE</source><volume>8</volume><elocation-id>e53419</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0053419</pub-id><pub-id pub-id-type="pmid">23301069</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>YH</given-names></name><name><surname>Nakayama</surname><given-names>T</given-names></name><name><surname>Nayak</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Glycolysis and the hexosamine biosynthetic pathway as novel targets for upper and lower airway inflammation</article-title><source>Allergy, Asthma &amp; Immunology Research</source><volume>10</volume><elocation-id>6</elocation-id><pub-id pub-id-type="doi">10.4168/aair.2018.10.1.6</pub-id><pub-id pub-id-type="pmid">29178672</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Konno</surname><given-names>M</given-names></name><name><surname>Asai</surname><given-names>A</given-names></name><name><surname>Kawamoto</surname><given-names>K</given-names></name><name><surname>Nishida</surname><given-names>N</given-names></name><name><surname>Satoh</surname><given-names>T</given-names></name><name><surname>Doki</surname><given-names>Y</given-names></name><name><surname>Mori</surname><given-names>M</given-names></name><name><surname>Ishii</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>The one-carbon metabolism pathway highlights therapeutic targets for gastrointestinal cancer (Review)</article-title><source>International Journal of Oncology</source><volume>50</volume><fpage>1057</fpage><lpage>1063</lpage><pub-id pub-id-type="doi">10.3892/ijo.2017.3885</pub-id><pub-id pub-id-type="pmid">28259896</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Konzman</surname><given-names>D</given-names></name><name><surname>Fukushige</surname><given-names>T</given-names></name><name><surname>Dagnachew</surname><given-names>M</given-names></name><name><surname>Krause</surname><given-names>M</given-names></name><name><surname>Hanover</surname><given-names>JA</given-names></name><name><surname>Ashrafi</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>O-GlcNAc transferase plays a non-catalytic role in <italic>C. elegans</italic> male fertility</article-title><source>PLOS Genetics</source><volume>18</volume><elocation-id>e1010273</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1010273</pub-id><pub-id pub-id-type="pmid">36383567</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lam</surname><given-names>AB</given-names></name><name><surname>Kervin</surname><given-names>K</given-names></name><name><surname>Tanis</surname><given-names>JE</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Vitamin B12 impacts amyloid beta-induced proteotoxicity by regulating the methionine/S-adenosylmethionine cycle</article-title><source>Cell Reports</source><volume>36</volume><elocation-id>109753</elocation-id><pub-id pub-id-type="doi">10.1016/j.celrep.2021.109753</pub-id><pub-id pub-id-type="pmid">34592146</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>BE</given-names></name><name><surname>Suh</surname><given-names>PG</given-names></name><name><surname>Kim</surname><given-names>JI</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>O-GlcNAcylation in health and neurodegenerative diseases</article-title><source>Experimental &amp; Molecular Medicine</source><volume>53</volume><fpage>1674</fpage><lpage>1682</lpage><pub-id pub-id-type="doi">10.1038/s12276-021-00709-5</pub-id><pub-id pub-id-type="pmid">34837015</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>F</given-names></name><name><surname>Sami</surname><given-names>A</given-names></name><name><surname>Noristani</surname><given-names>HN</given-names></name><name><surname>Slattery</surname><given-names>K</given-names></name><name><surname>Qiu</surname><given-names>J</given-names></name><name><surname>Groves</surname><given-names>T</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Veerasammy</surname><given-names>K</given-names></name><name><surname>Chen</surname><given-names>YX</given-names></name><name><surname>Morales</surname><given-names>J</given-names></name><name><surname>Haynes</surname><given-names>P</given-names></name><name><surname>Sehgal</surname><given-names>A</given-names></name><name><surname>He</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Song</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Glial metabolic rewiring promotes axon regeneration and functional recovery in the central nervous system</article-title><source>Cell Metabolism</source><volume>32</volume><fpage>767</fpage><lpage>785</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2020.08.015</pub-id><pub-id pub-id-type="pmid">32941799</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ligthart-Melis</surname><given-names>GC</given-names></name><name><surname>Engelen</surname><given-names>MP</given-names></name><name><surname>Simbo</surname><given-names>SY</given-names></name><name><surname>Ten Have</surname><given-names>GA</given-names></name><name><surname>Thaden</surname><given-names>JJ</given-names></name><name><surname>Cynober</surname><given-names>L</given-names></name><name><surname>Deutz</surname><given-names>NE</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Metabolic consequences of supplemented methionine in a clinical context</article-title><source>The Journal of Nutrition</source><volume>150</volume><fpage>2538S</fpage><lpage>2547S</lpage><pub-id pub-id-type="doi">10.1093/jn/nxaa254</pub-id><pub-id pub-id-type="pmid">33000166</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lionaki</surname><given-names>E</given-names></name><name><surname>Ploumi</surname><given-names>C</given-names></name><name><surname>Tavernarakis</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>One-carbon metabolism: Pulling the strings behind aging and neurodegeneration</article-title><source>Cells</source><volume>11</volume><elocation-id>214</elocation-id><pub-id pub-id-type="doi">10.3390/cells11020214</pub-id><pub-id pub-id-type="pmid">35053330</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>YJ</given-names></name><name><surname>Janssens</surname><given-names>GE</given-names></name><name><surname>McIntyre</surname><given-names>RL</given-names></name><name><surname>Molenaars</surname><given-names>M</given-names></name><name><surname>Kamble</surname><given-names>R</given-names></name><name><surname>Gao</surname><given-names>AW</given-names></name><name><surname>Jongejan</surname><given-names>A</given-names></name><name><surname>Weeghel</surname><given-names>MV</given-names></name><name><surname>MacInnes</surname><given-names>AW</given-names></name><name><surname>Houtkooper</surname><given-names>RH</given-names></name><name><surname>Murphy</surname><given-names>CT</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Glycine promotes longevity in <italic>Caenorhabditis elegans</italic> in a methionine cycle-dependent fashion</article-title><source>PLOS Genetics</source><volume>15</volume><elocation-id>e1007633</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1007633</pub-id><pub-id pub-id-type="pmid">30845140</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Locasale</surname><given-names>JW</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Serine, glycine and one-carbon units: cancer metabolism in full circle</article-title><source>Nature Reviews Cancer</source><volume>13</volume><fpage>572</fpage><lpage>583</lpage><pub-id pub-id-type="doi">10.1038/nrc3557</pub-id><pub-id pub-id-type="pmid">23822983</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lockridge</surname><given-names>A</given-names></name><name><surname>Hanover</surname><given-names>JA</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>A nexus of lipid and O-Glcnac metabolism in physiology and disease</article-title><source>Frontiers in Endocrinology</source><volume>13</volume><elocation-id>943576</elocation-id><pub-id pub-id-type="doi">10.3389/fendo.2022.943576</pub-id><pub-id pub-id-type="pmid">36111295</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mahar</surname><given-names>M</given-names></name><name><surname>Cavalli</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Intrinsic mechanisms of neuronal axon regeneration</article-title><source>Nature Reviews Neuroscience</source><volume>19</volume><fpage>323</fpage><lpage>337</lpage><pub-id pub-id-type="doi">10.1038/s41583-018-0001-8</pub-id><pub-id pub-id-type="pmid">29666508</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marshall</surname><given-names>S</given-names></name><name><surname>Bacote</surname><given-names>V</given-names></name><name><surname>Traxinger</surname><given-names>RR</given-names></name></person-group><year iso-8601-date="1991">1991</year><article-title>Discovery of a metabolic pathway mediating glucose-induced desensitization of the glucose transport system. Role of hexosamine biosynthesis in the induction of insulin resistance</article-title><source>Journal of Biological Chemistry</source><volume>266</volume><fpage>4706</fpage><lpage>4712</lpage><pub-id pub-id-type="doi">10.1016/S0021-9258(19)67706-9</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miousse</surname><given-names>IR</given-names></name><name><surname>Pathak</surname><given-names>R</given-names></name><name><surname>Garg</surname><given-names>S</given-names></name><name><surname>Skinner</surname><given-names>CM</given-names></name><name><surname>Melnyk</surname><given-names>S</given-names></name><name><surname>Pavliv</surname><given-names>O</given-names></name><name><surname>Hendrickson</surname><given-names>H</given-names></name><name><surname>Landes</surname><given-names>RD</given-names></name><name><surname>Lumen</surname><given-names>A</given-names></name><name><surname>Tackett</surname><given-names>AJ</given-names></name><name><surname>Deutz</surname><given-names>NEP</given-names></name><name><surname>Hauer-Jensen</surname><given-names>M</given-names></name><name><surname>Koturbash</surname><given-names>I</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Short-term dietary methionine supplementation affects one-carbon metabolism and DNA methylation in the mouse gut and leads to altered microbiome profiles, barrier function, gene expression and histomorphology</article-title><source>Genes &amp; Nutrition</source><volume>12</volume><elocation-id>22</elocation-id><pub-id pub-id-type="doi">10.1186/s12263-017-0576-0</pub-id><pub-id pub-id-type="pmid">28904640</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mutalik</surname><given-names>SP</given-names></name><name><surname>Gupton</surname><given-names>SL</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Glycosylation in Axonal Guidance</article-title><source>International Journal of Molecular Sciences</source><volume>22</volume><elocation-id>5143</elocation-id><pub-id pub-id-type="doi">10.3390/ijms22105143</pub-id><pub-id pub-id-type="pmid">34068002</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pacold</surname><given-names>ME</given-names></name><name><surname>Brimacombe</surname><given-names>KR</given-names></name><name><surname>Chan</surname><given-names>SH</given-names></name><name><surname>Rohde</surname><given-names>JM</given-names></name><name><surname>Lewis</surname><given-names>CA</given-names></name><name><surname>Swier</surname><given-names>LJYM</given-names></name><name><surname>Possemato</surname><given-names>R</given-names></name><name><surname>Chen</surname><given-names>WW</given-names></name><name><surname>Sullivan</surname><given-names>LB</given-names></name><name><surname>Fiske</surname><given-names>BP</given-names></name><name><surname>Cho</surname><given-names>S</given-names></name><name><surname>Freinkman</surname><given-names>E</given-names></name><name><surname>Birsoy</surname><given-names>K</given-names></name><name><surname>Abu-Remaileh</surname><given-names>M</given-names></name><name><surname>Shaul</surname><given-names>YD</given-names></name><name><surname>Liu</surname><given-names>CM</given-names></name><name><surname>Zhou</surname><given-names>M</given-names></name><name><surname>Koh</surname><given-names>MJ</given-names></name><name><surname>Chung</surname><given-names>H</given-names></name><name><surname>Davidson</surname><given-names>SM</given-names></name><name><surname>Luengo</surname><given-names>A</given-names></name><name><surname>Wang</surname><given-names>AQ</given-names></name><name><surname>Xu</surname><given-names>X</given-names></name><name><surname>Yasgar</surname><given-names>A</given-names></name><name><surname>Liu</surname><given-names>L</given-names></name><name><surname>Rai</surname><given-names>G</given-names></name><name><surname>Westover</surname><given-names>KD</given-names></name><name><surname>Vander Heiden</surname><given-names>MG</given-names></name><name><surname>Shen</surname><given-names>M</given-names></name><name><surname>Gray</surname><given-names>NS</given-names></name><name><surname>Boxer</surname><given-names>MB</given-names></name><name><surname>Sabatini</surname><given-names>DM</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>A PHGDH inhibitor reveals coordination of serine synthesis and one-carbon unit fate</article-title><source>Nature Chemical Biology</source><volume>12</volume><fpage>452</fpage><lpage>458</lpage><pub-id pub-id-type="doi">10.1038/nchembio.2070</pub-id><pub-id pub-id-type="pmid">27110680</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pravata</surname><given-names>VM</given-names></name><name><surname>Muha</surname><given-names>V</given-names></name><name><surname>Gundogdu</surname><given-names>M</given-names></name><name><surname>Ferenbach</surname><given-names>AT</given-names></name><name><surname>Kakade</surname><given-names>PS</given-names></name><name><surname>Vandadi</surname><given-names>V</given-names></name><name><surname>Wilmes</surname><given-names>AC</given-names></name><name><surname>Borodkin</surname><given-names>VS</given-names></name><name><surname>Joss</surname><given-names>S</given-names></name><name><surname>Stavridis</surname><given-names>MP</given-names></name><name><surname>van Aalten</surname><given-names>DMF</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Catalytic deficiency of O-GlcNAc transferase leads to X-linked intellectual disability</article-title><source>PNAS</source><volume>116</volume><fpage>14961</fpage><lpage>14970</lpage><pub-id pub-id-type="doi">10.1073/pnas.1900065116</pub-id><pub-id pub-id-type="pmid">31296563</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rao</surname><given-names>X</given-names></name><name><surname>Duan</surname><given-names>X</given-names></name><name><surname>Mao</surname><given-names>W</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Li</surname><given-names>Q</given-names></name><name><surname>Zheng</surname><given-names>Z</given-names></name><name><surname>Xu</surname><given-names>H</given-names></name><name><surname>Chen</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>PG</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Shen</surname><given-names>B</given-names></name><name><surname>Yi</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>O-GlcNAcylation of G6PD promotes the pentose phosphate pathway and tumor growth</article-title><source>Nature Communications</source><volume>6</volume><elocation-id>9468</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms9468</pub-id><pub-id pub-id-type="pmid">26399441</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rual</surname><given-names>J-F</given-names></name><name><surname>Ceron</surname><given-names>J</given-names></name><name><surname>Koreth</surname><given-names>J</given-names></name><name><surname>Hao</surname><given-names>T</given-names></name><name><surname>Nicot</surname><given-names>A-S</given-names></name><name><surname>Hirozane-Kishikawa</surname><given-names>T</given-names></name><name><surname>Vandenhaute</surname><given-names>J</given-names></name><name><surname>Orkin</surname><given-names>SH</given-names></name><name><surname>Hill</surname><given-names>DE</given-names></name><name><surname>van den Heuvel</surname><given-names>S</given-names></name><name><surname>Vidal</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Toward Improving        <italic>Caenorhabditis elegans</italic>        Phenome Mapping With an ORFeome-Based RNAi Library</article-title><source>Genome Research</source><volume>14</volume><fpage>2162</fpage><lpage>2168</lpage><pub-id pub-id-type="doi">10.1101/gr.2505604</pub-id><pub-id pub-id-type="pmid">15489339</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanderson</surname><given-names>SM</given-names></name><name><surname>Gao</surname><given-names>X</given-names></name><name><surname>Dai</surname><given-names>Z</given-names></name><name><surname>Locasale</surname><given-names>JW</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Methionine metabolism in health and cancer: a nexus of diet and precision medicine</article-title><source>Nature Reviews Cancer</source><volume>19</volume><fpage>625</fpage><lpage>637</lpage><pub-id pub-id-type="doi">10.1038/s41568-019-0187-8</pub-id><pub-id pub-id-type="pmid">31515518</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sbodio</surname><given-names>JI</given-names></name><name><surname>Snyder</surname><given-names>SH</given-names></name><name><surname>Paul</surname><given-names>BD</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Regulators of the transsulfuration pathway</article-title><source>British Journal of Pharmacology</source><volume>176</volume><fpage>583</fpage><lpage>593</lpage><pub-id pub-id-type="doi">10.1111/bph.14446</pub-id><pub-id pub-id-type="pmid">30007014</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soto</surname><given-names>J</given-names></name><name><surname>Rivera</surname><given-names>M</given-names></name><name><surname>Broitman-Maduro</surname><given-names>G</given-names></name><name><surname>Maduro</surname><given-names>MF</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Expression of a FRET-based ATP Biosensor in the <italic>C. elegans</italic> Intestine</article-title><source>MicroPubl Biol</source><volume>2020</volume><elocation-id>e284</elocation-id><pub-id pub-id-type="doi">10.17912/micropub.biology.000284</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stempler</surname><given-names>S</given-names></name><name><surname>Yizhak</surname><given-names>K</given-names></name><name><surname>Ruppin</surname><given-names>E</given-names></name><name><surname>Fong</surname><given-names>SS</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Integrating transcriptomics with metabolic modeling predicts biomarkers and drug targets for alzheimer’s disease</article-title><source>PLOS ONE</source><volume>9</volume><elocation-id>e105383</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0105383</pub-id><pub-id pub-id-type="pmid">25127241</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Su</surname><given-names>C</given-names></name><name><surname>Schwarz</surname><given-names>TL</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title><italic>O</italic>-GlcNAc Transferase Is Essential for Sensory Neuron Survival and Maintenance</article-title><source>The Journal of Neuroscience</source><volume>37</volume><fpage>2125</fpage><lpage>2136</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.3384-16.2017</pub-id><pub-id pub-id-type="pmid">28115479</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>L</given-names></name><name><surname>Shay</surname><given-names>J</given-names></name><name><surname>McLoed</surname><given-names>M</given-names></name><name><surname>Roodhouse</surname><given-names>K</given-names></name><name><surname>Chung</surname><given-names>SH</given-names></name><name><surname>Clark</surname><given-names>CM</given-names></name><name><surname>Pirri</surname><given-names>JK</given-names></name><name><surname>Alkema</surname><given-names>MJ</given-names></name><name><surname>Gabel</surname><given-names>CV</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Neuronal regeneration in <italic>C. elegans</italic> Requires subcellular calcium release by ryanodine receptor channels and can be enhanced by optogenetic stimulation</article-title><source>The Journal of Neuroscience</source><volume>34</volume><fpage>15947</fpage><lpage>15956</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.4238-13.2014</pub-id><pub-id pub-id-type="pmid">25429136</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tabatabaie</surname><given-names>L</given-names></name><name><surname>Klomp</surname><given-names>LW</given-names></name><name><surname>Berger</surname><given-names>R</given-names></name><name><surname>de Koning</surname><given-names>TJ</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>L-Serine synthesis in the central nervous system: A review on serine deficiency disorders</article-title><source>Molecular Genetics and Metabolism</source><volume>99</volume><fpage>256</fpage><lpage>262</lpage><pub-id pub-id-type="doi">10.1016/j.ymgme.2009.10.012</pub-id><pub-id pub-id-type="pmid">19963421</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taub</surname><given-names>DG</given-names></name><name><surname>Awal</surname><given-names>MR</given-names></name><name><surname>Gabel</surname><given-names>CV</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>O-GlcNAc Signaling Orchestrates the Regenerative Response to Neuronal Injury in <italic>Caenorhabditis elegans</italic></article-title><source>Cell Reports</source><volume>24</volume><fpage>1931</fpage><lpage>1938</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2018.07.078</pub-id><pub-id pub-id-type="pmid">30134155</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tian</surname><given-names>JL</given-names></name><name><surname>Huang</surname><given-names>CW</given-names></name><name><surname>Eslami</surname><given-names>F</given-names></name><name><surname>Mannino</surname><given-names>MP</given-names></name><name><surname>Mai</surname><given-names>RL</given-names></name><name><surname>Hart</surname><given-names>GW</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Regulation of Primary Cilium Length by O-GlcNAc during Neuronal Development in a Human Neuron Model</article-title><source>Cells</source><volume>12</volume><elocation-id>1520</elocation-id><pub-id pub-id-type="doi">10.3390/cells12111520</pub-id><pub-id pub-id-type="pmid">37296641</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tracey</surname><given-names>TJ</given-names></name><name><surname>Steyn</surname><given-names>FJ</given-names></name><name><surname>Wolvetang</surname><given-names>EJ</given-names></name><name><surname>Ngo</surname><given-names>ST</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Neuronal lipid metabolism: Multiple pathways driving functional outcomes in health and disease</article-title><source>Frontiers in Molecular Neuroscience</source><volume>11</volume><elocation-id>10</elocation-id><pub-id pub-id-type="doi">10.3389/fnmol.2018.00010</pub-id><pub-id pub-id-type="pmid">29410613</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vitvitsky</surname><given-names>V</given-names></name><name><surname>Thomas</surname><given-names>M</given-names></name><name><surname>Ghorpade</surname><given-names>A</given-names></name><name><surname>Gendelman</surname><given-names>HE</given-names></name><name><surname>Banerjee</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>A functional transsulfuration pathway in the brain links to glutathione homeostasis</article-title><source>Journal of Biological Chemistry</source><volume>281</volume><fpage>35785</fpage><lpage>35793</lpage><pub-id pub-id-type="doi">10.1074/jbc.M602799200</pub-id><pub-id pub-id-type="pmid">17005561</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walker</surname><given-names>AK</given-names></name><name><surname>Jacobs</surname><given-names>RL</given-names></name><name><surname>Watts</surname><given-names>JL</given-names></name><name><surname>Rottiers</surname><given-names>V</given-names></name><name><surname>Jiang</surname><given-names>K</given-names></name><name><surname>Finnegan</surname><given-names>DM</given-names></name><name><surname>Shioda</surname><given-names>T</given-names></name><name><surname>Hansen</surname><given-names>M</given-names></name><name><surname>Yang</surname><given-names>F</given-names></name><name><surname>Niebergall</surname><given-names>LJ</given-names></name><name><surname>Vance</surname><given-names>DE</given-names></name><name><surname>Tzoneva</surname><given-names>M</given-names></name><name><surname>Hart</surname><given-names>AC</given-names></name><name><surname>Näär</surname><given-names>AM</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>A conserved SREBP-1/Phosphatidylcholine Feedback circuit regulates lipogenesis in metazoans</article-title><source>Cell</source><volume>147</volume><fpage>840</fpage><lpage>852</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2011.09.045</pub-id><pub-id pub-id-type="pmid">22035958</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walker</surname><given-names>AK</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>1-Carbon cycle metabolites methylate their way to fatty liver</article-title><source>Trends in Endocrinology &amp; Metabolism</source><volume>28</volume><fpage>63</fpage><lpage>72</lpage><pub-id pub-id-type="doi">10.1016/j.tem.2016.10.004</pub-id><pub-id pub-id-type="pmid">27789099</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Jin</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>D</given-names></name><name><surname>Li</surname><given-names>D</given-names></name><name><surname>Hao</surname><given-names>F</given-names></name><name><surname>Feng</surname><given-names>Y</given-names></name><name><surname>Gu</surname><given-names>S</given-names></name><name><surname>Meng</surname><given-names>F</given-names></name><name><surname>Tian</surname><given-names>M</given-names></name><name><surname>Zheng</surname><given-names>Y</given-names></name><name><surname>Xin</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Han</surname><given-names>X</given-names></name><name><surname>Aravind</surname><given-names>L</given-names></name><name><surname>Wei</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title><italic>O-</italic> GlcNAcylation destabilizes the active tetrameric PKM2 to promote the Warburg effect</article-title><source>PNAS</source><volume>114</volume><fpage>13732</fpage><lpage>13737</lpage><pub-id pub-id-type="doi">10.1073/pnas.1704145115</pub-id><pub-id pub-id-type="pmid">29229835</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>YL</given-names></name><name><surname>Grooms</surname><given-names>NWF</given-names></name><name><surname>Chung</surname><given-names>SH</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Transverse and axial resolution of femtosecond laser ablation</article-title><source>Journal of Biophotonics</source><volume>15</volume><elocation-id>e42</elocation-id><pub-id pub-id-type="doi">10.1002/jbio.202200042</pub-id><pub-id pub-id-type="pmid">35583201</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watson</surname><given-names>E</given-names></name><name><surname>Olin-Sandoval</surname><given-names>V</given-names></name><name><surname>Hoy</surname><given-names>MJ</given-names></name><name><surname>Li</surname><given-names>CH</given-names></name><name><surname>Louisse</surname><given-names>T</given-names></name><name><surname>Yao</surname><given-names>V</given-names></name><name><surname>Mori</surname><given-names>A</given-names></name><name><surname>Holdorf</surname><given-names>AD</given-names></name><name><surname>Troyanskaya</surname><given-names>OG</given-names></name><name><surname>Ralser</surname><given-names>M</given-names></name><name><surname>Walhout</surname><given-names>AJ</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Metabolic network rewiring of propionate flux compensates vitamin B12 deficiency in <italic>C. elegans</italic></article-title><source>eLife</source><volume>5</volume><elocation-id>e17670</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.17670</pub-id><pub-id pub-id-type="pmid">27383050</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname><given-names>C</given-names></name><name><surname>Giono</surname><given-names>LE</given-names></name><name><surname>Rozés-Salvador</surname><given-names>V</given-names></name><name><surname>Fiszbein</surname><given-names>A</given-names></name><name><surname>Kornblihtt</surname><given-names>AR</given-names></name><name><surname>Cáceres</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>The histone methyltransferase g9a controls axon growth by targeting the RhoA Signaling pathway</article-title><source>Cell Reports</source><volume>31</volume><elocation-id>107639</elocation-id><pub-id pub-id-type="doi">10.1016/j.celrep.2020.107639</pub-id><pub-id pub-id-type="pmid">32402271</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>Q</given-names></name><name><surname>Gao</surname><given-names>ZJ</given-names></name><name><surname>Yu</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Dietary regulation in health and disease</article-title><source>Signal Transduction and Targeted Therapy</source><volume>7</volume><elocation-id>252</elocation-id><pub-id pub-id-type="doi">10.1038/s41392-022-01104-w</pub-id><pub-id pub-id-type="pmid">35871218</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>M</given-names></name><name><surname>Vousden</surname><given-names>KH</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Serine and one-carbon metabolism in cancer</article-title><source>Nature Reviews Cancer</source><volume>16</volume><fpage>650</fpage><lpage>662</lpage><pub-id pub-id-type="doi">10.1038/nrc.2016.81</pub-id><pub-id pub-id-type="pmid">27634448</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>C</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Chen</surname><given-names>W</given-names></name><name><surname>Lu</surname><given-names>N</given-names></name><name><surname>Siniossoglou</surname><given-names>S</given-names></name><name><surname>Yao</surname><given-names>Z</given-names></name><name><surname>Liu</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Rewiring neuronal glycerolipid metabolism determines the extent of axon regeneration</article-title><source>Neuron</source><volume>105</volume><fpage>276</fpage><lpage>292</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2019.10.009</pub-id><pub-id pub-id-type="pmid">31786011</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yi</surname><given-names>W</given-names></name><name><surname>Clark</surname><given-names>PM</given-names></name><name><surname>Mason</surname><given-names>DE</given-names></name><name><surname>Keenan</surname><given-names>MC</given-names></name><name><surname>Hill</surname><given-names>C</given-names></name><name><surname>Goddard</surname><given-names>WA</given-names><suffix>III</suffix></name><name><surname>Peters</surname><given-names>EC</given-names></name><name><surname>Driggers</surname><given-names>EM</given-names></name><name><surname>Hsieh-Wilson</surname><given-names>LC</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Phosphofructokinase 1 glycosylation regulates cell growth and metabolism</article-title><source>Science</source><volume>337</volume><fpage>975</fpage><lpage>980</lpage><pub-id pub-id-type="doi">10.1126/science.1222278</pub-id><pub-id pub-id-type="pmid">22923583</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>L</given-names></name><name><surname>Teoh</surname><given-names>ST</given-names></name><name><surname>Ensink</surname><given-names>E</given-names></name><name><surname>Ogrodzinski</surname><given-names>MP</given-names></name><name><surname>Yang</surname><given-names>C</given-names></name><name><surname>Vazquez</surname><given-names>AI</given-names></name><name><surname>Lunt</surname><given-names>SY</given-names></name></person-group><year iso-8601-date="2019">2019a</year><article-title>Cysteine catabolism and the serine biosynthesis pathway support pyruvate production during pyruvate kinase knockdown in pancreatic cancer cells</article-title><source>Cancer &amp; Metabolism</source><volume>7</volume><elocation-id>13</elocation-id><pub-id pub-id-type="doi">10.1186/s40170-019-0205-z</pub-id><pub-id pub-id-type="pmid">31893043</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>W</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Zhang</surname><given-names>K</given-names></name><name><surname>Chi</surname><given-names>Z</given-names></name><name><surname>Xu</surname><given-names>T</given-names></name><name><surname>Jiang</surname><given-names>D</given-names></name><name><surname>Chen</surname><given-names>S</given-names></name><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Yang</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Wu</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2019">2019b</year><article-title>One-carbon metabolism supports s-adenosylmethionine and histone methylation to drive inflammatory macrophages</article-title><source>Molecular Cell</source><volume>75</volume><fpage>1147</fpage><lpage>1160</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2019.06.039</pub-id><pub-id pub-id-type="pmid">31420217</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>S</given-names></name><name><surname>Banerjee</surname><given-names>D</given-names></name><name><surname>Kuhn</surname><given-names>JR</given-names></name><name><surname>Bergmann</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Isolation and culture of larval cells from <italic>C. elegans</italic></article-title><source>PLOS ONE</source><volume>6</volume><elocation-id>e19505</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0019505</pub-id><pub-id pub-id-type="pmid">21559335</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>X</given-names></name><name><surname>Boyer</surname><given-names>L</given-names></name><name><surname>Jin</surname><given-names>M</given-names></name><name><surname>Mertens</surname><given-names>J</given-names></name><name><surname>Kim</surname><given-names>Y</given-names></name><name><surname>Ma</surname><given-names>L</given-names></name><name><surname>Ma</surname><given-names>L</given-names></name><name><surname>Hamm</surname><given-names>M</given-names></name><name><surname>Gage</surname><given-names>FH</given-names></name><name><surname>Hunter</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Metabolic reprogramming during neuronal differentiation from aerobic glycolysis to neuronal oxidative phosphorylation</article-title><source>eLife</source><volume>5</volume><elocation-id>e13374</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.13374</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zogg</surname><given-names>CK</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Phosphoglycerate dehydrogenase: Potential therapeutic target and putative metabolic oncogene</article-title><source>Journal of Oncology</source><volume>2014</volume><fpage>1</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1155/2014/524101</pub-id><pub-id pub-id-type="pmid">25574168</pub-id></element-citation></ref></ref-list><app-group><app id="appendix-1"><title>Appendix 1</title><p>Key resource table: List of <italic>E. coli</italic> and <italic>C. elegans</italic> strains, Chemicals, Drugs, Kits, and RT-PCR primers used in this study.</p><table-wrap id="app1keyresource" position="anchor"><label>Appendix 1—key resources table</label><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Reagent type (species) or resource</th><th align="left" valign="bottom">Designation</th><th align="left" valign="bottom">Source or reference</th><th align="left" valign="bottom">Identifiers</th><th align="left" valign="bottom">Additional information</th></tr></thead><tbody><tr><td align="left" valign="bottom">Strain, strain background (<italic>Escherichia coli</italic>)</td><td align="left" valign="bottom"><italic>Caenorhabditis</italic> Genetics Centre</td><td align="left" valign="bottom">Wormbase, <italic>E. coli</italic> OP50</td><td align="left" valign="bottom">WBStrain00041969</td><td align="left" valign="bottom">Other names:<break/>CBb1</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">Source Bioscience</td><td align="left" valign="bottom">Vidal and Ahringer RNAi Libraries in HT115 (D3) <italic>E. coli</italic></td><td align="left" valign="bottom"/><td align="left" valign="bottom">RNAi Library</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">L-methionine</td><td align="left" valign="bottom">Fisher Scientific</td><td align="left" valign="bottom">Cat#: AC166160025 CAS: 63-68-3</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">L-Cystathionine</td><td align="left" valign="bottom">Sigma</td><td align="left" valign="bottom">Cat#: C7505-10MG</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">L-Methionine</td><td align="left" valign="bottom">Sigma</td><td align="left" valign="bottom">Cat#: M-9625</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">L-Serine</td><td align="left" valign="bottom">Sigma</td><td align="left" valign="bottom">Cat#: S-4500</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Choline Chloride</td><td align="left" valign="bottom">Millipore Sigma</td><td align="left" valign="bottom">Cat#: C7017-5G, CAS:67-48-1</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Sodium Chloride (NaCl)</td><td align="left" valign="bottom">Fisher Bioreagents</td><td align="left" valign="bottom">Cat#: BP358-1 CAS:7647-14-5</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">β-meracaptoethanol</td><td align="left" valign="bottom">Fisher Scientific</td><td align="left" valign="bottom">Cat#: AC125470100 CAS: 60-24-2</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Trizol</td><td align="left" valign="bottom">ThermoFisher Scientific</td><td align="left" valign="bottom">Cat#: 15596018</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">PowerUp SYBR Green Master Mix</td><td align="left" valign="bottom">Applied Biosystems</td><td align="left" valign="bottom">Cat#: A25741</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Agarose</td><td align="left" valign="bottom">Fisher Bioreagents</td><td align="left" valign="bottom">Cat#: BP160-500, CAS: 9012-36-6</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Pronase</td><td align="left" valign="bottom">Sigma- Aldrich</td><td align="left" valign="bottom">SKU# 10165921001</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">DMSO (Dimethyl Sulfoxide)</td><td align="left" valign="bottom">ThermoFisher Scientific</td><td align="left" valign="bottom">Cat#: 85190, Cas:67-68-5</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Water, Molecular Grade, Sterile, DEPC Free</td><td align="left" valign="bottom">Fisher Scientific</td><td align="left" valign="bottom">CAS: 7732-18-5 Cat#: R91450001G,</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">NCT502</td><td align="left" valign="bottom">MedChemExpress (MCE)</td><td align="left" valign="bottom">Cat#: HY-117240</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Polybead polystyrene</td><td align="left" valign="bottom">Polysciences</td><td align="left" valign="bottom">Cat#08691–10</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom"> ATP Assay Kit (Colorometric/ Fluorometric)</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">Ab83355</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">Pyrophosphate Assay Kit (Fluorometric)</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">Ab112155</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">Pyruvate Kinase (PK) Assay Kit (Colorimetric)</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">Ab83432</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">BCA Protein Quantification Kit</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">Ab102536</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom"> RNAeasy columns</td><td align="left" valign="bottom">QIAGEN</td><td align="left" valign="bottom">Cat#74034</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">Direct-zol RNA Miniprep Plus Kit</td><td align="left" valign="bottom">Zymo Research</td><td align="left" valign="bottom">Cat# R2070</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>C. elegans</italic>)</td><td align="left" valign="bottom">SK4005</td><td align="left" valign="bottom">Taub <italic>et. al</italic>.</td><td align="left" valign="bottom"/><td align="left" valign="bottom">WT (zdis5 pmec-4::GFP)</td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>C. elegans</italic>)</td><td align="left" valign="bottom">NA</td><td align="left" valign="bottom">Taub <italic>et. al</italic>.</td><td align="left" valign="bottom"/><td align="left" valign="bottom"><italic>ogt-1</italic>(ok1474)_zdis-5 pmec-4::GFP</td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>C. elegans</italic>)</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://cgc.umn.edu/strain/OG1135">OG1135</ext-link></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom"><italic>Ogt-1</italic> (OG1135)<italic>_TU3568_ pmec-4::GFP</italic></td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>C. elegans</italic>)</td><td align="left" valign="bottom">RB1342</td><td align="left" valign="bottom">Taub <italic>et. al</italic>.</td><td align="left" valign="bottom"/><td align="left" valign="bottom"><italic>ogt-1</italic>(ok1474)</td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>C. elegans</italic>)</td><td align="left" valign="bottom">NA</td><td align="left" valign="bottom">Taub <italic>et. al</italic>.</td><td align="left" valign="bottom"/><td align="left" valign="bottom">TU3568 (sid-1(pk3321) him-5(e1490) V; lin-15B(n744) X; uIs71[(pCFJ90) pmyo-2::mCherry +pmec-18::sid-1])</td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>C. elegans</italic>)</td><td align="left" valign="bottom">NA</td><td align="left" valign="bottom">Taub <italic>et. al</italic>.</td><td align="left" valign="bottom"/><td align="left" valign="bottom"><italic>ogt-1</italic>(ok1474)_TU3568</td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>C. elegans</italic>)</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://cgc.umn.edu/strain/RB2240">RB2240</ext-link></td><td align="left" valign="bottom">CGC</td><td align="left" valign="bottom"/><td align="left" valign="bottom"><italic>sams-1</italic>(ok3033)</td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>C. elegans</italic>)</td><td align="left" valign="bottom">NA</td><td align="left" valign="bottom">in this study</td><td align="left" valign="bottom"/><td align="left" valign="bottom"><italic>sams-1</italic>_zdis-5</td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>C. elegans</italic>)</td><td align="left" valign="bottom">NA</td><td align="left" valign="bottom">in this study</td><td align="left" valign="bottom"/><td align="left" valign="bottom"><italic>ogt-1;sams-1</italic>_zdis-5</td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>C. elegans</italic>)</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://cgc.umn.edu/strain/RB755">RB755</ext-link></td><td align="left" valign="bottom">CGC</td><td align="left" valign="bottom"/><td align="left" valign="bottom"><italic>metr-1</italic>(R03D7.1(ok521))</td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>C. elegans</italic>)</td><td align="left" valign="bottom">NA</td><td align="left" valign="bottom">in this study</td><td align="left" valign="bottom"/><td align="left" valign="bottom"><italic>metr-1</italic>_zdis-5</td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>C. elegans</italic>)</td><td align="left" valign="bottom">NA</td><td align="left" valign="bottom">in this study</td><td align="left" valign="bottom"/><td align="left" valign="bottom"><italic>ogt-1;metr-1</italic>_zdis-5</td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>C. elegans</italic>)</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://cgc.umn.edu/strain/VC1011">VC1011</ext-link></td><td align="left" valign="bottom">CGC</td><td align="left" valign="bottom"/><td align="left" valign="bottom"><italic>acdh-1</italic>(ok1489)</td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>C. elegans</italic>)</td><td align="left" valign="bottom">NA</td><td align="left" valign="bottom">in this study</td><td align="left" valign="bottom"/><td align="left" valign="bottom"><italic>acdh-1</italic>_zdis-5</td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>C. elegans</italic>)</td><td align="left" valign="bottom">NA</td><td align="left" valign="bottom">in this study</td><td align="left" valign="bottom"/><td align="left" valign="bottom"><italic>ogt-1;acdh-1</italic>_zdis-5</td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>C. elegans</italic>)</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://cgc.umn.edu/strain/RB512">RB512</ext-link></td><td align="left" valign="bottom">CGC</td><td align="left" valign="bottom"/><td align="left" valign="bottom"><italic>mce-1</italic>(D2030.5(ok243))</td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>C. elegans</italic>)</td><td align="left" valign="bottom">NA</td><td align="left" valign="bottom">in this study</td><td align="left" valign="bottom"/><td align="left" valign="bottom"><italic>mce-1</italic>_zdis-5</td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>C. elegans</italic>)</td><td align="left" valign="bottom">NA</td><td align="left" valign="bottom">in this study</td><td align="left" valign="bottom"/><td align="left" valign="bottom"><italic>mce-1</italic>_TU3568_zdis-5</td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>C. elegans</italic>)</td><td align="left" valign="bottom">NA</td><td align="left" valign="bottom">in this study</td><td align="left" valign="bottom"/><td align="left" valign="bottom"><italic>ogt-1;mce-1</italic>_TU3568_zdis-5</td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>C. elegans</italic>)</td><td align="left" valign="bottom">CG122</td><td align="left" valign="bottom">Taub <italic>et. al</italic>.</td><td align="left" valign="bottom"/><td align="left" valign="bottom"><italic>ogt-1;akt-1</italic>(mg144)</td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>C. elegans</italic>)</td><td align="left" valign="bottom">CG125</td><td align="left" valign="bottom">Taub <italic>et. al</italic>.</td><td align="left" valign="bottom"/><td align="left" valign="bottom"><italic>ogt-1;akt-1</italic>(ok525)</td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>C. elegans</italic>)</td><td align="left" valign="bottom">MS2495</td><td align="left" valign="bottom">Soto and Rivera <italic>et. al</italic>.</td><td align="left" valign="bottom"/><td align="left" valign="bottom">irIs158 (normal ATP sensor, CAmA)</td></tr><tr><td align="left" valign="bottom">Strain, strain background (<italic>C. elegans</italic>)</td><td align="left" valign="bottom">NA</td><td align="left" valign="bottom">In this study</td><td align="left" valign="bottom"/><td align="left" valign="bottom"><italic>ogt-1; CAmA</italic></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>folr-1_F</italic></td><td align="left" valign="bottom">C17G1.1</td><td align="left" valign="bottom">RT-qPCR</td><td align="left" valign="bottom"><named-content content-type="sequence">GGCTTCCATTGCCGTCATAA</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>folr-1_R</italic></td><td align="left" valign="bottom">C17G1.1</td><td align="left" valign="bottom">RT-qPCR</td><td align="left" valign="bottom"><named-content content-type="sequence">GCTAACCACTGGCTCACGAT</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>metr-1_F</italic></td><td align="left" valign="bottom">R03D7.1</td><td align="left" valign="bottom">RT-qPCR</td><td align="left" valign="bottom"><named-content content-type="sequence">CCCGAATCGCAGTTATCCGA</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>metr-1_R</italic></td><td align="left" valign="bottom">R03D7.1</td><td align="left" valign="bottom">RT-qPCR</td><td align="left" valign="bottom"><named-content content-type="sequence">GAAGCAGCTGGGAGGAATGA</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>sams-1_F</italic></td><td align="left" valign="bottom">C49F5.1</td><td align="left" valign="bottom">RT-qPCR</td><td align="left" valign="bottom"><named-content content-type="sequence">CACTCACCGACGAAGAGCTT</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>sams-1_R</italic></td><td align="left" valign="bottom">C49F5.1</td><td align="left" valign="bottom">RT-qPCR</td><td align="left" valign="bottom"><named-content content-type="sequence">GTGACCGAAGTGACCGTTCT</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>dmat-1_F</italic></td><td align="left" valign="bottom">C18A3.1</td><td align="left" valign="bottom">RT-qPCR</td><td align="left" valign="bottom"><named-content content-type="sequence">ATTGCCGATCCACCATGGTT</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>dmat-1_R</italic></td><td align="left" valign="bottom">C18A3.1</td><td align="left" valign="bottom">RT-qPCR</td><td align="left" valign="bottom"><named-content content-type="sequence">CCGATTTGTGATCCAGAAAGCA</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>nmad-1_F</italic></td><td align="left" valign="bottom">F09F7.7</td><td align="left" valign="bottom">RT-qPCR</td><td align="left" valign="bottom"><named-content content-type="sequence">GCACAGTCACAAAGTGGTCG</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>nmad-1_R</italic></td><td align="left" valign="bottom">F09F7.7</td><td align="left" valign="bottom">RT-qPCR</td><td align="left" valign="bottom"><named-content content-type="sequence">CGTACTCTGGCATTCCGACA</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>cth-1_F</italic></td><td align="left" valign="bottom">F22B8.6</td><td align="left" valign="bottom">RT-qPCR</td><td align="left" valign="bottom"><named-content content-type="sequence">TCTGATATTATTATGGGAGCCGC</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>cth-1_R</italic></td><td align="left" valign="bottom">F22B8.6</td><td align="left" valign="bottom">RT-qPCR</td><td align="left" valign="bottom"><named-content content-type="sequence">TGCAGTCATGAGCTTCAAGGA</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>cth-2_F</italic></td><td align="left" valign="bottom">ZK1127.10</td><td align="left" valign="bottom">RT-qPCR</td><td align="left" valign="bottom"><named-content content-type="sequence">TTGGAGCGGATGTTGTCGTT</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>cth-2_R</italic></td><td align="left" valign="bottom">ZK1127.10</td><td align="left" valign="bottom">RT-qPCR</td><td align="left" valign="bottom"><named-content content-type="sequence">AGTGAGCTCTCATTCTGATGTGA</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>pcca-1_F</italic></td><td align="left" valign="bottom">F27D9.5</td><td align="left" valign="bottom">RT-qPCR</td><td align="left" valign="bottom"><named-content content-type="sequence">AAATGGGAGAACAGGCCGTT</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>pcca-1_R</italic></td><td align="left" valign="bottom">F27D9.5</td><td align="left" valign="bottom">RT-qPCR</td><td align="left" valign="bottom"><named-content content-type="sequence">TGGGTGATTGGAAGTGGGTG</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>pccb-1_F</italic></td><td align="left" valign="bottom">F52E4.1</td><td align="left" valign="bottom">RT-qPCR</td><td align="left" valign="bottom"><named-content content-type="sequence">AAAGTTTGCTGCTGGATGCC</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>pccb-1_R</italic></td><td align="left" valign="bottom">F52E4.1</td><td align="left" valign="bottom">RT-qPCR</td><td align="left" valign="bottom"><named-content content-type="sequence">AATCTTTGGAACGGTGGCCT</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>mce-1_F</italic></td><td align="left" valign="bottom">D2030.5</td><td align="left" valign="bottom">RT-qPCR</td><td align="left" valign="bottom"><named-content content-type="sequence">TGTCCACAAGAACCATGGCT</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>mce-1_R</italic></td><td align="left" valign="bottom">D2030.5</td><td align="left" valign="bottom">RT-qPCR</td><td align="left" valign="bottom"><named-content content-type="sequence">CGCCGAATGGATGAAGAAGC</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>mmcm-1_F</italic></td><td align="left" valign="bottom">ZK1058.1</td><td align="left" valign="bottom">RT-qPCR</td><td align="left" valign="bottom"><named-content content-type="sequence">CAATGTTGCCGATCCTTGGG</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>mmcm-1_R</italic></td><td align="left" valign="bottom">ZK1058.1</td><td align="left" valign="bottom">RT-qPCR</td><td align="left" valign="bottom"><named-content content-type="sequence">TCCAACAATCACATCTTTTCCAGC</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>acdh-1_F</italic></td><td align="left" valign="bottom">C55B7.4</td><td align="left" valign="bottom">RT-qPCR</td><td align="left" valign="bottom"><named-content content-type="sequence">TCCGAGCTTCATCCACTTGT</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>acdh-1_R</italic></td><td align="left" valign="bottom">C55B7.4</td><td align="left" valign="bottom">RT-qPCR</td><td align="left" valign="bottom"><named-content content-type="sequence">CTGACCGAACTGTTCTCTCTGT</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>ech-6_F</italic></td><td align="left" valign="bottom">T05G5.6</td><td align="left" valign="bottom">RT-qPCR</td><td align="left" valign="bottom"><named-content content-type="sequence">AGGTGGAAACGAGTTGGCAA</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>ech-6_R</italic></td><td align="left" valign="bottom">T05G5.6</td><td align="left" valign="bottom">RT-qPCR</td><td align="left" valign="bottom"><named-content content-type="sequence">GCTCACAATACCGTGCTCCT</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>hach-1_F</italic></td><td align="left" valign="bottom">F09F7.4</td><td align="left" valign="bottom">RT-qPCR</td><td align="left" valign="bottom"><named-content content-type="sequence">AGTCATCAGATCGTTCGAGCC</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>hach-1_R</italic></td><td align="left" valign="bottom">F09F7.4</td><td align="left" valign="bottom">RT-qPCR</td><td align="left" valign="bottom"><named-content content-type="sequence">TCGGTGATTTGTCGGTGAGT</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>hphd-1_F</italic></td><td align="left" valign="bottom">Y38F1A.6</td><td align="left" valign="bottom">RT-qPCR</td><td align="left" valign="bottom"><named-content content-type="sequence">CAAAGATCTCCACGCCCTGA</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>hphd-1_R</italic></td><td align="left" valign="bottom">Y38F1A.6</td><td align="left" valign="bottom">RT-qPCR</td><td align="left" valign="bottom"><named-content content-type="sequence">GGAGAGTCCGTGGCAAAGAT</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>alh-8_F</italic></td><td align="left" valign="bottom">F13D12.4</td><td align="left" valign="bottom">RT-qPCR</td><td align="left" valign="bottom"><named-content content-type="sequence">GGGAGCTCAGGTTCCACTTG</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>alh-8_R</italic></td><td align="left" valign="bottom">F13D12.4</td><td align="left" valign="bottom">RT-qPCR</td><td align="left" valign="bottom"><named-content content-type="sequence">TGAAGATGGCCGTTCCGTTT</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>act-1_F</italic></td><td align="left" valign="bottom">T04C12.6</td><td align="left" valign="bottom">RT-qPCR</td><td align="left" valign="bottom"><named-content content-type="sequence">TCGGTATGGGACAGAAGGAC</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"><italic>act-1_R</italic></td><td align="left" valign="bottom">T04C12.6</td><td align="left" valign="bottom">RT-qPCR</td><td align="left" valign="bottom"><named-content content-type="sequence">CATCCCAGTTGGTGACGATA</named-content></td></tr></tbody></table></table-wrap></app></app-group></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.86478.sa0</article-id><title-group><article-title>Editor's evaluation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Cochella</surname><given-names>Luisa</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00za53h95</institution-id><institution>Johns Hopkins University</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><related-object id="sa0ro1" object-id-type="id" object-id="10.1101/2023.03.05.531166" link-type="continued-by" xlink:href="https://sciety.org/articles/activity/10.1101/2023.03.05.531166"/></front-stub><body><p>This important work reveals that increased flux towards one carbon metabolism improves neuronal regeneration after injury in <italic>C. elegans</italic>. The presented data are solid and provide compelling support for this conclusion.</p></body></sub-article><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.86478.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Cochella</surname><given-names>Luisa</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00za53h95</institution-id><institution>Johns Hopkins University</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Hanover</surname><given-names>John A</given-names></name><role>Reviewer</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00adh9b73</institution-id><institution>National Institute of Diabetes and Digestive and Kidney Diseases</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text id="sa2-box1"><p>Our editorial process produces two outputs: (i) <ext-link ext-link-type="uri" xlink:href="https://sciety.org/articles/activity/10.1101/2023.03.05.531166">public reviews</ext-link> designed to be posted alongside <ext-link ext-link-type="uri" xlink:href="https://www.biorxiv.org/content/10.1101/2023.03.05.531166v1">the preprint</ext-link> for the benefit of readers; (ii) feedback on the manuscript for the authors, including requests for revisions, shown below. We also include an acceptance summary that explains what the editors found interesting or important about the work.</p></boxed-text><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;O-GlcNAc Signaling Increases Neuron Regeneration Through One-Carbon Metabolism in <italic>Caenorhabditis elegans</italic>&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by 2 peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Piali Sengupta as the Senior Editor.</p><p>The reviewers have discussed their reviews with one another, and the Reviewing Editor has drafted this to help you prepare a revised submission.</p><p>Essential revisions:</p><p>1. Confirm results with another allele of ogt-1 (possibly a catalytic dead allele as well).</p><p>2. Improve the clarity of the presentation: the figures were not always clear, and their schematics of metabolic pathways could certainly be more clear, but also the images of the regenerated axons: it was not clear to me what they are measuring – according to the methods they cut two points and measure regeneration in between, but figures only show one arrow and the axons all look continuous at that point.</p><p>3. Either perform experiments OR adapt the data interpretation to disambiguate the following point: The authors use the phrase &quot; enhanced glycolysis&quot; in ogt-1 mutant. They don't show any evidence for this. In the multiply branched pathway(s) of glycolysis the process can be enhanced due to the reduced activity of pyk-1 in got-1 + pyk-1 mutant.</p><p>4. There are a number of additional comments and suggestions for improvement listed below.</p><p><italic>Reviewer #2 (Recommendations for the authors):</italic></p><p>This is a potentially important finding regarding the roles of O-GlcNAc cycling and one-carbon metabolism in nerve regeneration. In a previous paper (Taub et al. 2018): they showed: Both ogt-1 and oga-1 mutants show the strong activation of neuronal regeneration phenotype. However, the different biological processes used for the neural regeneration phenotype of between ogt-1 and oga-1 mutant.</p><p>The phenotype of ogt-1 mutant for the axon regeneration is that ARK-1 activates AKT-1 to regulate the activation of glycolysis. DAF-16 is not involved in this regeneration process (daf-16 independent). The function of mitochondria (nduf-2.2 and nuo-6 mutant) is assessed in this neural regeneration phenotype of ogt-1. The phenotype of oga-1 mutant for the axon regeneration is dependent upon DAF-16.</p><p>A mild modulator of SGK-1 regulated the activity of DAF-16, but not AKT-1. Furthermore, the reduction of mitochondria function (nduf-2.2 mutant) suppressed the neural regeneration of oga-1 mutant. These findings provide the premise for the current work.</p><p>My comments about this paper:</p><p>Overall, the approach is intriguing and well-documented. The authors find effectors (components of One-carbon metabolism) downstream of the ogt-1 mutant. If they test the following, their current data would be more solid:</p><p>The authors use gfat-1 and gfat-2 to mimic the phenotype of ogt-1 mutant, due to the reduction of UDP-GlcNAc for O- GlcNAcylation. However, it is not clear if they tested the phenotype of ogt-1; oga-1 double mutants for neural regeneration. Since they show that both ogt-1 and oga-1 mutants show a similar neuronal regeneration phenotype, but they use different biological pathways. As described above, it is better to assess the neural regeneration phenotype of the oga-1 mutant to determine if high levels of o-glycosylation in the oga-1 mutant occurs. Is the phenotype related to o-glycosylation function in oga-1 mutant? Alternatively, they can check the expression levels of pyk-1 in gfat-1, and gfat-2, and oga-1mutants. The expression level of pyk-1 mutant is down in the ogt-1 mutant by using whole worms, but the authors don't mention the levels of pyk-1 in single cell RNA seq in this paper (Figure 2).</p><p>The reviewer checked their single-cell RNA seq data in Supp. Figure 2E and F. None of their selected genes (including pyk-1) which suppress the neural regeneration phenotype of ogt-1 are not listed in this Supp. Figure 2E and F (only pathway analysis by DAVID like enrichment software)? Alternatively, they need to show data for their selected genes.</p><p>They also test an atp-3 mutant which affects ATP production. The atp-3 mutant suppressed the neural regeneration phenotype of ogt-1 mutant. This implicates that the overall level of ATP is important to promote the neural regeneration phenotype of ogt-1. (one-carbon metabolism is also linked ATP production). They previously tested nduf-2.2 and nuo-6 mutants for the mitochondrial respiratory chain complex I. However, the lipid consumption in the ogt-1 mutant is greatly impaired, and β-oxidation is important to generate ATP, due to an inefficient glycolysis pathway. They could test the suppression of ogt-1 phenotype by acs-2 and cpt-1 (or other neuronal opt mutant(s)) for the activity of the β-oxidation pathway.</p><p>The focus in this paper is on the one-carbon metabolism genes, because their previous paper described that pfk-1.1 and pgk-1 suppress the neural regeneration phenotype of ogt-1. It appears that pyk-1 does not affect ogt-1 phenotype, but pyk-1 by itself shows a similar phenotype to that of ogt-1. According to these results, they focus on the 3-PG branch of the metabolic pathway in the Glycolysis pathway for the neural regeneration phenotype of ogt-1. It would seem important to also see data for the interaction of β-oxidation and ogt-1.</p><p>The authors use the phrase &quot; enhanced glycolysis&quot; in ogt-1 mutant. They don't show any evidence for this. In the multiply branched pathway(s) of glycolysis the process can be enhanced due to the reduced activity of pyk-1 in got-1 + pyk-1 mutant. This should be clarified in the discussion of the findings.</p><p>Is OGT-1 activity necessary for the phenotype? Were more alleles of ogt-1 tested? OGT alleles both phenotypically and in their extent of penetrance. The authors should at least comment on this in the current paper. Several recent papers have used catalytically dead mutants to assess this. References to these and other relevant papers should be included</p><p>In summary, this is a potentially important finding which upon further documentation will be an excellent contribution.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.86478.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>1. Confirm results with another allele of ogt-1 (possibly a catalytic dead allele as well).</p></disp-quote><p>We have now performed the in vivo regeneration experiment in worms with catalytically dead ogt-1 allele (strain OG1155). Results are similar to those of the <italic>ogt-1</italic> deletion mutation and are now incorporated in the Results section (Figure 1B, line 98-102).</p><disp-quote content-type="editor-comment"><p>2. Improve the clarity of the presentation: the figures were not always clear, and their schematics of metabolic pathways could certainly be more clear, but also the images of the regenerated axons: it was not clear to me what they are measuring – according to the methods they cut two points and measure regeneration in between, but figures only show one arrow and the axons all look continuous at that point.</p></disp-quote><p>Thank you for bringing up this issue. In accordance, we have redrawn the metabolic pathways including all the essential information. We have also included both ablation points in regenerating axon figures and added the details of measurements in the method section (line 523-529).</p><disp-quote content-type="editor-comment"><p>3. Either perform experiments OR adapt the data interpretation to disambiguate the following point: The authors use the phrase &quot; enhanced glycolysis&quot; in ogt-1 mutant. They don't show any evidence for this. In the multiply branched pathway(s) of glycolysis the process can be enhanced due to the reduced activity of pyk-1 in got-1 + pyk-1 mutant.</p></disp-quote><p>Thank you for bringing up this point and we agree that our results do not explicitly demonstrate “enhanced glycolysis”. We have, therefore, removed this phrase throughout the text, referring instead to specific elements of the glycolytic pathway that are implicated. For example, Results section 1 now refers to our specific findings on “Blocking the Hexosamine Biosynthesis Pathway (HBP)”.</p><disp-quote content-type="editor-comment"><p>4. There are a number of additional comments and suggestions for improvement listed below.</p></disp-quote><p>We reviewed all suggestions and comments, have made changes to the manuscript as required and responded to the reviewers below.</p><disp-quote content-type="editor-comment"><p>Reviewer #2 (Recommendations for the authors):</p><p>This is a potentially important finding regarding the roles of O-GlcNAc cycling and one-carbon metabolism in nerve regeneration. In a previous paper (Taub et al. 2018): they showed: Both ogt-1 and oga-1 mutants show the strong activation of neuronal regeneration phenotype. However, the different biological processes used for the neural regeneration phenotype of between ogt-1 and oga-1 mutant.</p><p>The phenotype of ogt-1 mutant for the axon regeneration is that ARK-1 activates AKT-1 to regulate the activation of glycolysis. DAF-16 is not involved in this regeneration process (daf-16 independent). The function of mitochondria (nduf-2.2 and nuo-6 mutant) is assessed in this neural regeneration phenotype of ogt-1. The phenotype of oga-1 mutant for the axon regeneration is dependent upon DAF-16.</p><p>A mild modulator of SGK-1 regulated the activity of DAF-16, but not AKT-1. Furthermore, the reduction of mitochondria function (nduf-2.2 mutant) suppressed the neural regeneration of oga-1 mutant. These findings provide the premise for the current work.</p><p>My comments about this paper:</p><p>Overall, the approach is intriguing and well-documented. The authors find effectors (components of One-carbon metabolism) downstream of the ogt-1 mutant. If they test the following, their current data would be more solid:</p><p>The authors use gfat-1 and gfat-2 to mimic the phenotype of ogt-1 mutant, due to the reduction of UDP-GlcNAc for O- GlcNAcylation. However, it is not clear if they tested the phenotype of ogt-1; oga-1 double mutants for neural regeneration. Since they show that both ogt-1 and oga-1 mutants show a similar neuronal regeneration phenotype, but they use different biological pathways. As described above, it is better to assess the neural regeneration phenotype of the oga-1 mutant to determine if high levels of o-glycosylation in the oga-1 mutant occurs. Is the phenotype related to o-glycosylation function in oga-1 mutant? Alternatively, they can check the expression levels of pyk-1 in gfat-1, and gfat-2, and oga-1mutants. The expression level of pyk-1 mutant is down in the ogt-1 mutant by using whole worms, but the authors don't mention the levels of pyk-1 in single cell RNA seq in this paper (Figure 2).</p></disp-quote><p>We are thankful to the reviewer for such a detailed summarization of our manuscript and insightful suggestions. The reviewer wishes to know the level of O-glycosylation in the <italic>oga-1</italic> mutant. In our previous manuscript (Taub et al. 2018): we have demonstrated that <italic>oga-1</italic> mutation leads to higher levels of O-glycosylation (Taub et al. 2018, Figure 1C). However, our current manuscript is focused on identification of metabolic pathways involved in enhanced neuronal regeneration in <italic>ogt-1</italic> worms. In an effort to maintain the focus of the current study we did not investigate either O-glycosylation levels in the <italic>oga-1,</italic> or expression level of pyk-1/gfat-1/gfat-2 in <italic>oga-1</italic> worms. However, we agree this would be an interesting topic of investigation in future work.</p><p>In <italic>ogt-1</italic>, we did observe expression changes in pyk-1 (-1.0 fold), gfat-1 (-1.8 fold) and gfat-2 (-5.4 fold) in neuronal RNAseq data (Table S3, this manuscript). We have now added this information in the manuscript text (Results section 2, line166-167) and comment on their potential relevance.</p><disp-quote content-type="editor-comment"><p>The reviewer checked their single-cell RNA seq data in Supp. Figure 2E and F. None of their selected genes (including pyk-1) which suppress the neural regeneration phenotype of ogt-1 are not listed in this Supp. Figure 2E and F (only pathway analysis by DAVID like enrichment software)? Alternatively, they need to show data for their selected genes.</p></disp-quote><p>We apologize that our presentation of this data was not clear. Figure 2—figure supplement 1E and 1F list only the top 50 up and down regulated genes and therefore do not contain all genes that are differentially regulated. Rather all differentially expressed genes (including pyk-1, gfat-1 and gfat-2) are listed in Table S3 WT-vs-ogt-1 DEGs tab. As mentioned above, we have included these specific results for pyk-1, gfat-1 and gfat-2 in our manuscript text as well. In addition, please note: In this study we have performed neuronal RNAseq but not single cell RNAseq.</p><disp-quote content-type="editor-comment"><p>They also test an atp-3 mutant which affects ATP production. The atp-3 mutant suppressed the neural regeneration phenotype of ogt-1 mutant. This implicates that the overall level of ATP is important to promote the neural regeneration phenotype of ogt-1. (one-carbon metabolism is also linked ATP production). They previously tested nduf-2.2 and nuo-6 mutants for the mitochondrial respiratory chain complex I. However, the lipid consumption in the ogt-1 mutant is greatly impaired, and β-oxidation is important to generate ATP, due to an inefficient glycolysis pathway. They could test the suppression of ogt-1 phenotype by acs-2 and cpt-1 (or other neuronal opt mutant(s)) for the activity of the β-oxidation pathway.</p></disp-quote><p>We thank the reviewer for this insightful comment regarding the β-oxidation pathway. Following this suggestion, we performed regeneration experiments with neuron specific RNAi knockdown against acs-2 and cpt-2 to investigate lipid β-oxidation as a potential link of OCM and ATP generation. However, we did not observe any effect of either acs-2 or cpt-2 knockdown on regeneration in ogt-1 animals (Figure 4—figure supplement 1C). Thus, the β-oxidation pathway does not appear to play an essential role in regeneration which we now present at the end of Results section 4 (line 317-323). Regardless, this additional data adds to the completeness of our study, and we thank the reviewer for their suggestion.</p><disp-quote content-type="editor-comment"><p>The focus in this paper is on the one-carbon metabolism genes, because their previous paper described that pfk-1.1 and pgk-1 suppress the neural regeneration phenotype of ogt-1. It appears that pyk-1 does not affect ogt-1 phenotype, but pyk-1 by itself shows a similar phenotype to that of ogt-1. According to these results, they focus on the 3-PG branch of the metabolic pathway in the Glycolysis pathway for the neural regeneration phenotype of ogt-1. It would seem important to also see data for the interaction of β-oxidation and ogt-1.</p></disp-quote><p>Again, we are thankful for the suggestion regarding the possible link between the β-oxidation pathway and ogt-1. As discussed above, we have now performed regeneration experiments with neuron specific RNAi against acs-2 and cpt-2 to investigate lipid β-oxidation as a potential link of OCM and ATP generation. However, we did not observe any effect on regeneration in ogt-1 animals (Figure 4—figure supplement 1C) suggesting this is not the case.</p><disp-quote content-type="editor-comment"><p>The authors use the phrase &quot; enhanced glycolysis&quot; in ogt-1 mutant. They don't show any evidence for this. In the multiply branched pathway(s) of glycolysis the process can be enhanced due to the reduced activity of pyk-1 in got-1 + pyk-1 mutant. This should be clarified in the discussion of the findings.</p></disp-quote><p>Thank you for bringing this to our attention. We agree that our results do not explicitly demonstrate “enhance glycolysis”. We have changed the phrasing in both the results and Discussion sections to eliminate this claim and explain our findings in a more precise and proper way. We now refer to specific elements of the glycolytic pathway that are directly implicated. Furthermore, we also discuss the plausibility of up regulation of additional glycolytic pathways in ogt-1 mutants and pyk-1 knock down animals in the discussion (line 403-409).</p><disp-quote content-type="editor-comment"><p>Is OGT-1 activity necessary for the phenotype? Were more alleles of ogt-1 tested? OGT alleles both phenotypically and in their extent of penetrance. The authors should at least comment on this in the current paper. Several recent papers have used catalytically dead mutants to assess this. References to these and other relevant papers should be included</p></disp-quote><p>As suggested, we have now performed regeneration experiments with the OGT-1 enzymatic dead allele strain (OG1135) (Figure. 1B, main manuscript Results section 1 line 98-102 and Discussion section line 340-343). Here, we measured similar enhanced regeneration as in ogt-1(deletion) mutant animals, suggesting that it is indeed the loss of OGT-1 enzymatic activity that alters neuron regeneration. These results further support findings in our earlier study, Taub et al. 2018, in which wildtype animals treated with an OGT inhibitor (ST045849; Figure S2A, Taub et al), that reduces enzymatic activity, displayed increased regeneration while similar treatment of ogt-1 animals did not (Figures 1E Taub et al). We further tested the effect of The Hexosamine Biosynthesis Pathway (using RNAi against <italic>gfat-1</italic> and <italic>gfat-2</italic> genes) which is essential to generate UDP-O-GlcNAC, the substrate used by OGT-1 for O-GlcNACylation. This also enhanced regeneration, Figure 1C, suggesting that a shift in metabolic flux towards glycolysis is important. These results are in agreement with our earlier study that ARK-1 and AKT-1 is essential for regeneration in <italic>ogt-1</italic> animals (Taub et al. 2018). The results with the <italic>ogt-1</italic> dead allele further support these conclusions and we are thankful for the suggestion.</p></body></sub-article></article>